KR20210156913A - Organic light-emitting compound and organic electroluminescent device using the same - Google Patents

Organic light-emitting compound and organic electroluminescent device using the same Download PDF

Info

Publication number
KR20210156913A
KR20210156913A KR1020200074331A KR20200074331A KR20210156913A KR 20210156913 A KR20210156913 A KR 20210156913A KR 1020200074331 A KR1020200074331 A KR 1020200074331A KR 20200074331 A KR20200074331 A KR 20200074331A KR 20210156913 A KR20210156913 A KR 20210156913A
Authority
KR
South Korea
Prior art keywords
group
formula
chloro
aryl
compound
Prior art date
Application number
KR1020200074331A
Other languages
Korean (ko)
Inventor
김진웅
엄민식
김회문
정화순
배형찬
손호준
한송이
Original Assignee
솔루스첨단소재 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 솔루스첨단소재 주식회사 filed Critical 솔루스첨단소재 주식회사
Priority to KR1020200074331A priority Critical patent/KR20210156913A/en
Priority to PCT/KR2021/007608 priority patent/WO2021256871A1/en
Publication of KR20210156913A publication Critical patent/KR20210156913A/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/24Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to three ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • H01L51/0054
    • H01L51/0067
    • H01L51/0071
    • H01L51/0073
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/16Electron transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/18Carrier blocking layers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The present invention relates to a novel compound having excellent light emitting ability and an organic electroluminescent device comprising the same, and the compound according to the present invention is used in an organic material layer material of the organic electroluminescent device, preferably an electron transport layer material and an electron transport auxiliary layer material, thereby being able to improve the luminous efficiency, driving voltage, lifespan, etc. of the organic electroluminescent device.

Description

유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자 {ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME}Organic light emitting compound and organic electroluminescent device using same

본 발명은 신규한 유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자에 관한 것으로, 보다 상세하게는 전자수송 능력이 우수한 화합물 및 이를 하나 이상의 유기물층에 포함함으로써 발광효율, 구동 전압, 수명 등의 특성이 향상된 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic light emitting compound and an organic electroluminescent device using the same, and more particularly, to a compound having excellent electron transport ability and an organic compound having improved characteristics such as luminous efficiency, driving voltage, and lifespan by including the compound in one or more organic material layers. It relates to an electroluminescent device.

1950년대 Bernanose의 유기 박막 발광 관측을 시점으로 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광 (electroluminescent, EL) 소자(이하, 간단히 '유기 EL 소자'로 칭함)에 대한 연구는 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층구조의 유기 EL 소자가 제시되었다. 이후 고효율, 고수명의 유기 EL 소자를 만들기 위하여, 소자 내 각각의 특징적인 유기물 층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다. A study on organic electroluminescent (EL) devices (hereinafter simply referred to as 'organic EL devices') that led to blue electroluminescence using anthracene single crystals in 1965, starting with Bernanose's observation of organic thin film emission in the 1950s, began in 1987. (Tang) presented an organic EL device having a stacked structure divided into a functional layer of a hole layer and a light emitting layer. Since then, in order to make a high-efficiency, long-life organic EL device, it has been developed in the form of introducing each characteristic organic material layer in the device, leading to the development of a specialized material used for this.

유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 이때 유기물층으로 사용되는 물질은 그 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. When a voltage is applied between the two electrodes of the organic electroluminescent device, holes are injected from the anode, and electrons are injected into the organic material layer from the cathode. When the injected holes and electrons meet, an exciton is formed, and when the exciton falls to the ground state, light is emitted. In this case, the material used as the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material, etc. according to their function.

유기 EL 소자의 발광층 형성재료는 발광색에 따라 청색, 녹색, 적색 발광 재료로 구분될 수 있다. 그밖에, 보다 나은 천연색을 구현하기 위한 발광재료로 노란색 및 주황색 발광재료도 사용된다. 또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 재료로서 호스트/도펀트 계를 사용할 수 있다. 도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 이러한 인광 재료의 개발은 이론적으로 형광에 비해 4배까지의 발광 효율을 향상시킬 수 있어 인광 도판트 뿐만 아니라 인광 호스트 재료들에 대해 관심이 집중되고 있다. The material for forming the light emitting layer of the organic EL device may be classified into blue, green, and red light emitting materials according to the emission color. In addition, yellow and orange light emitting materials are also used as light emitting materials for realizing better natural colors. In addition, in order to increase color purity and increase luminous efficiency through energy transfer, a host/dopant system may be used as a light emitting material. The dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. The development of such a phosphorescent material can theoretically improve luminous efficiency up to four times compared to fluorescence, and thus, attention is focused on phosphorescent host materials as well as phosphorescent dopants.

현재까지 정공 주입층, 정공 수송층. 정공 차단층, 전자 수송층으로는, 하기 화학식으로 표현된 NPB, BCP, Alq3 등이 널리 알려져 있고, 발광 재료는 안트라센 유도체들이 형광 도판트/호스트 재료로서 보고되고 있다. 특히 발광재료 중 효율 향상 측면에서 큰 장점을 가지고 있는 인광 재료로서는 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물이 청색, 녹색, 적색 도판트 재료로 사용되고 있다. 현재까지는 CBP가 인광 호스트 재료로 우수한 특성을 나타내고 있다. Until now, hole injection layer, hole transport layer. As the hole blocking layer and the electron transporting layer, NPB, BCP, Alq 3, etc. represented by the following chemical formulas are widely known, and anthracene derivatives have been reported as fluorescent dopant/host materials as light emitting materials. In particular, among the light emitting materials, as a phosphorescent material having a great advantage in terms of efficiency improvement , a metal complex compound containing Ir such as Firpic, Ir(ppy) 3 , (acac)Ir(btp) 2 , etc. is a blue, green, and red dopant material. is being used as So far, CBP has shown excellent properties as a phosphorescent host material.

Figure pat00001
Figure pat00001

Figure pat00002
Figure pat00002

그러나 기존의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮고 열적 안정성이 매우 좋지 않아 유기 EL 소자에서의 수명 측면에서 만족할만한 수준이 되지 못하고 있다.However, although the existing materials have advantages in terms of luminescent properties, they are not satisfactory in terms of lifespan in organic EL devices due to their low glass transition temperature and very poor thermal stability.

대한민국 공개특허 제10-2015-0033082호 (공개일자 : 2015. 04. 01)Republic of Korea Patent Publication No. 10-2015-0033082 (published date: 04. 01, 2015)

본 발명은 특정 헤테로환 화합물을 유기 전계 발광 소자에 적용할 수 있으며, 상기 특정 헤테로환 화합물을 유기 전계 발광소자의 공통층인 전자수송층(ETL) 재료로 사용하여 저전압, 고효율 및 장수명 특성을 모두 우수한 신규 유기 화합물을 제공하는 것을 목적으로 한다.In the present invention, a specific heterocyclic compound can be applied to an organic electroluminescent device, and the specific heterocyclic compound is used as an electron transport layer (ETL) material, which is a common layer of an organic electroluminescent device. An object of the present invention is to provide a novel organic compound.

또한, 본 발명은 상기 신규 유기 화합물을 포함하여 낮은 구동 전압과 높은 발광 효율을 나타내며 수명이 향상되고 전자 주입 및 수송능이 개선된 전자 수송층용 재료, 정공 주입 및 수송능이 개선된 정공수송층 재료 및 이를 포함하는 유기 전계 발광 소자를 제공하는 것을 또 다른 목적으로 한다.In addition, the present invention includes a material for an electron transport layer with improved lifespan and improved electron injection and transport ability, a hole transport layer material with improved hole injection and transport ability, and a material for the hole transport layer including the novel organic compound, which exhibits low driving voltage and high luminous efficiency, and includes the same Another object of the present invention is to provide an organic electroluminescent device.

상기한 목적을 달성하기 위해, 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.In order to achieve the above object, the present invention provides a compound represented by the following formula (1).

[화학식 1][Formula 1]

Figure pat00003
Figure pat00003

상기 화학식 1에서,In Formula 1,

L1 및 L2는 각각 독립적으로 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18개의 헤테로아릴렌기로 이루어진 군에서 선택되며,L1 and L2 are each independently a single bond, or C 6 ~ C 18 is selected from the group consisting of an arylene group and a heteroarylene group having 5 to 18 nuclear atoms,

n 은 0 내지 3의 정수이며,n is an integer from 0 to 3,

상기 A 및 B는 각각 독립적으로 하기 화학식 2 내지 화학식 4 중 어느 하나로 표시되는 치환기이며,A and B are each independently a substituent represented by any one of the following Chemical Formulas 2 to 4,

[화학식 2][Formula 2]

Figure pat00004
Figure pat00004

[화학식 3][Formula 3]

Figure pat00005
Figure pat00005

[화학식 4][Formula 4]

Figure pat00006
Figure pat00006

상기 화학식 2 내지 화학식 4에서,In Formulas 2 to 4,

*는 결합이 이루어지는 부분이고,* is the part where the bond is made,

복수의 X는 서로 동일하거나 상이하고, 각각 독립적으로 C(R) 또는 N이나, B로 표시되는 화학식 2 및 화학식 3에 의한 X는 적어도 둘 이상이 N이며,A plurality of Xs are the same or different from each other, and each independently C (R) or N, but X by Formula 2 and Formula 3 represented by B is at least two or more N,

R은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 서로 인접하는 기와 지방족, 방향족, 지방족헤테로 또는 방향족헤테로의 축합 고리를 형성하거나 스피로 결합을 이룰 수 있고,R is hydrogen, deuterium, halogen, cyano group, nitro group, C1~ C40 alkyl group, C2~ C4 0 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 nuclear atoms to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 Arylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 60 Aryl boron group, C 6 ~ C 60 Arylphosphine group, C 6 ~ mono or diaryl phosphine of C 60 blood group and a C 6 ~ C is selected from the 60 group consisting of aryl amines, form a condensed ring of the group aliphatic, aromatic, aliphatic hetero, or aromatic heterocyclic group which are adjacent to each other, or to achieve a spiro bond there is,

상기 R의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있으며,R of an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, a cycloalkyl group, a heterocycloalkyl group, an arylamine group, an alkylsilyl group, an alkylboron group, an arylboron group, an aryl group Phosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryl Amine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkylboron group, C 6 ~ C 60 aryl boron group, C 6 ~ C substituted with at least 60 of the aryl phosphine group, C 6 ~ C 60 mono or diaryl phosphine blood group and a C 6 ~ selected from the group consisting arylsilyl of C 60 one kind of substituent or being unsubstituted , when substituted with a plurality of substituents, they may be the same or different from each other,

m 은 0 내지 3의 정수이며,m is an integer from 0 to 3,

Ar1이 복수인 경우, 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 알킬이거나, 치환 또는 비치환된 알케닐기이거나, 치환 또는 비치환된 알키닐기이거나, 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기이며, 인접한 X와 축합 고리를 형성할 수 있으며,When Ar1 is plural, the same or different from each other, and each independently is a substituted or unsubstituted alkyl, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted aryl group, It is a substituted or unsubstituted heteroaryl group, and may form a condensed ring with adjacent X,

Ar2 및 Ar3은 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기일 수 있다.Ar2 and Ar3 may be the same as or different from each other, and each independently may be a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group.

또한, 본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하고, 상기 1층 이상의 유기물 층에서 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.In addition, the present invention includes an anode, a cathode, and one or more organic material layers interposed between the positive and negative electrodes, wherein at least one of the one or more organic layers includes a compound represented by Formula 1 above. A light emitting device is provided.

여기서, 상기 화학식 1로 표시되는 화합물을 포함하는 1층 이상의 유기물층 중 적어도 하나는 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자수송 보조층 및 전자 주입층으로 이루어진 군으로부터 선택될 수 있으며, 전자 수송층, 전자수송 보조층 및/또는 발광층인 것이 바람직하다. 이때 상기 화학식 1로 표시되는 화합물은 전자 수송층 재료, 전자 수송 보조층 재료 및/또는 발광층 재료이다.Here, at least one of the one or more organic material layers including the compound represented by Formula 1 may be selected from the group consisting of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron transport auxiliary layer, and an electron injection layer, It is preferably a transport layer, an electron transport auxiliary layer and/or a light emitting layer. In this case, the compound represented by Formula 1 is an electron transport layer material, an electron transport auxiliary layer material, and/or a light emitting layer material.

본 발명의 화합물은 발광 효율, 구동 전압, 수명 등이 우수하기 때문에 유기 전계 발광 소자의 유기물층 재료로 유용하게 적용될 수 있으며, 본 발명의 화합물을 유기물층에 포함하는 유기 전계 발광 소자는 발광 효율, 구동 전압, 수명, 효율 등의 측면이 크게 향상되어 풀 칼라 디스플레이 패널 등에 효과적으로 적용될 수 있다.Since the compound of the present invention has excellent luminous efficiency, driving voltage, lifespan, etc., it can be usefully applied as an organic material layer material of an organic electroluminescent device. , life, efficiency, etc. are greatly improved, so that it can be effectively applied to a full-color display panel.

도 1은 본 발명의 일 실시예에 따른 유기 전계 발광 소자의 단면도를 나타낸 것이다.
도 2는 본 발명의 일 실시예에 따른 유기 전계 발광 소자의 단면도를 나타낸 것이다.
1 is a cross-sectional view of an organic electroluminescent device according to an embodiment of the present invention.
2 is a cross-sectional view of an organic electroluminescent device according to an embodiment of the present invention.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

1. 유기화합물1. Organic compounds

본 발명은 발광 효율, 구동 전압, 수명 등이 우수한 신규 크리센계 화합물을 제공한다.The present invention provides a novel chrysene-based compound having excellent luminous efficiency, driving voltage, lifespan, and the like.

구체적으로, 본 발명에 따른 신규 유기 화합물은 크리센계(Chrysene)를 코어(core)로 채택하고, 상기 코어 구조에 전자 수송능이 뛰어난 전자끄는기(electron withdrawing group: EWG)가 결합되어 기본 골격을 이룬다.Specifically, the novel organic compound according to the present invention adopts Chrysene as a core, and an electron withdrawing group (EWG) having excellent electron transport ability is bonded to the core structure to form a basic skeleton. .

이러한 구조의 화학식 1로 표시되는 화합물은, 크리센에 알킬과 아릴이 축합된 형태의 결합을 통한 치환기를 형성함에 따라, 기존에 알려진 6원의 헤테로환 구조에 비해 전기화학적으로 안정하고, 전자 이동성이 우수할 뿐만 아니라 높은 유리 전이온도 및 열적 안정이 우수하다. 또한, 전자이동속도를 향상시키기 위하여 평면적인 구조(Flat form)을 가지며 짧은 콘쥬게이션 길이(Conjugation length)에 따라 높은 삼중항 에너지(Triplet energy)를 가져 발광층에서 생성된 엑시톤(exciton)이 인접하는 전자 수송층 또는 정공 수송층으로 확산(이동)되는 것을 방지할 수 있다. 따라서 발광층 내에서 발광에 기여하는 엑시톤의 수가 증가되어 본 발명의 화학식 1의 화합물을 유기 전계 발광 소자에 사용할 경우, 우수한 열적 안정성 및 캐리어 수송능(특히, 전자 수송능 및 발광능)을 기대할 수 있을 뿐만 아니라 소자의 구동전압, 효율, 수명 등이 향상될 수 있고, 높은 삼중항 에너지에 의해 최신 ETL 재료로서 TTF(triplet-triplet fusion) 효과로 인한 우수한 효율 상승을 나타낼 수 있다.The compound represented by Chemical Formula 1 having such a structure is electrochemically stable compared to the conventionally known 6-membered heterocyclic structure by forming a substituent through a condensed bond of alkyl and aryl to chrysene, and electron mobility. Not only this is excellent, but it also has excellent high glass transition temperature and thermal stability. In addition, in order to improve the electron transfer rate, it has a flat form and has high triplet energy according to a short conjugation length so that excitons generated in the light emitting layer are adjacent electrons. Diffusion (migration) to the transport layer or the hole transport layer can be prevented. Therefore, when the compound of Formula 1 of the present invention is used in an organic electroluminescent device because the number of excitons contributing to light emission in the light emitting layer is increased, excellent thermal stability and carrier transport ability (especially, electron transport ability and light emitting ability) can be expected. In addition, the driving voltage, efficiency, lifespan, etc. of the device can be improved, and excellent efficiency increase due to the triplet-triplet fusion (TTF) effect can be exhibited as the latest ETL material by high triplet energy.

또한, 본 발명의 화학식 1로 표시되는 화합물들은 치환기의 방향이나 위치에 따라 HOMO 및 LUMO 에너지 레벨을 조절이 용이하여, 이러한 화합물을 사용한 유기 전계 발광 소자에서 높은 전자 수송성을 보일 수 있다.In addition, the compounds represented by Formula 1 of the present invention can easily control HOMO and LUMO energy levels depending on the direction or position of a substituent, and thus can exhibit high electron transport properties in an organic electroluminescent device using such a compound.

아울러, 본 발명에서는 융합된 크리센 코어에, 정공(hole)과 전자(electron)에 대한 양쪽성의 물리화학적 성질을 가진 디벤조계 모이어티[예, dibenzofuran (DBF) 또는 dibenzothiophene (DBT)]를 적어도 하나 이상 포함할 수 있다. 이러한 디벤조계 모이어티와 강력한 electron-withdrawing group(EWG)인 질소 함유 방향족환(예, pyridine, pyrazine, triazine)과의 조합을 통해 우수한 발광효율 특성을 가진 그린 인광재료로서 적용할 수 있다. 또한, 저전압 구동이 가능하여 수명 상승 효과를 나타낼 수 있으며, 열적 안정성, 높은 유리전이온도 특성 및 균일한 모폴로지(morphology)를 가져 소자 특성이 우수하다.In addition, in the present invention, at least a dibenzo-based moiety [eg, dibenzofuran (DBF) or dibenzothiophene (DBT)] having an amphoteric physicochemical property for a hole and an electron is added to the fused chrysene core. It may include more than one. It can be applied as a green phosphorescent material with excellent luminous efficiency through the combination of such a dibenzo-based moiety and a nitrogen-containing aromatic ring (eg, pyridine, pyrazine, triazine), which is a strong electron-withdrawing group (EWG). In addition, it is possible to drive at a low voltage, thereby exhibiting an effect of increasing the lifespan, and has excellent device characteristics due to thermal stability, high glass transition temperature characteristics, and uniform morphology.

전술한 바와 같이, 본 발명의 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 유기물층 재료, 바람직하게는 발광층 재료(청색, 녹색 및/또는 적색의 인광 호스트 재료), 전자 수송층/주입층 재료, 전자수송보조층 재료, 정공 수송층/주입층 재료, 발광 보조층 재료, 수명 개선층 재료로 적용할 경우, 유기 전계 발광 소자의 성능 및 수명 특성이 크게 향상될 수 있다. 이러한 유기 전계 발광 소자는 결과적으로 풀 칼라 유기 발광 패널의 성능을 극대화시킬 수 있다.As described above, the compound represented by Formula 1 of the present invention is an organic material layer material of an organic electroluminescent device, preferably a light emitting layer material (blue, green and/or red phosphorescent host material), electron transport layer/injection layer material, electron When applied as a transport auxiliary layer material, a hole transport layer/injection layer material, a light emitting auxiliary layer material, and a life improvement layer material, the performance and lifespan characteristics of the organic electroluminescent device can be greatly improved. As a result, such an organic electroluminescent device can maximize the performance of a full color organic light emitting panel.

이러한 화학식 1로 표시되는 화합물에서, 상기 L1 및 L2는 각각 독립적으로 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18개의 헤테로아릴렌기로 이루어진 군에서 선택되고, 상기 n 은 0 내지 3의 정수이다.In the compound represented by this formula (1), L1 and L2 are each independently a single bond, or selected from the group consisting of a C 6 ~ C 18 arylene group and a heteroarylene group having 5 to 18 nuclear atoms, wherein n is an integer from 0 to 3.

상기 화학식 2 내지 화학식 4에서, *는 결합이 이루어지는 부분이고, 복수의 X는 서로 동일하거나 상이하고, 각각 독립적으로 C(R) 또는 N이나, B로 표시되는 화학식 2 및 화학식 3에 의한 X는 적어도 둘 이상이 N이며, R은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 서로 인접하는 기와 지방족, 방향족, 지방족헤테로 또는 방향족헤테로의 축합 고리를 형성하거나 스피로 결합을 이룰 수 있고,In Formulas 2 to 4, * is a portion where a bond is formed, a plurality of Xs are the same or different from each other, and each independently C (R) or N, but X represented by Formula 2 and Formula 3 represented by B is At least two or more are N, R is hydrogen, deuterium, halogen, cyano group, nitro group, C1~ C40 alkyl group, C2~ C4 0 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 Cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 6 to C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 1 to C 40 alkyloxy group, C 6 to C 60 Aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 Arylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 60 Aryl boron group, C 6 ~ C 60 An arylphosphine group, a C 6 ~ C 60 mono or diaryl phosphinyl group and a C 6 ~ C 60 arylamine group selected from the group, and a condensed ring of an aliphatic, aromatic, aliphatic hetero or aromatic hetero with a group adjacent to each other can form or form spiro bonds,

상기 R의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있으며, m 은 0 내지 3의 정수이며, Ar1이 복수인 경우, 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 알킬이거나, 치환 또는 비치환된 알케닐기이거나, 치환 또는 비치환된 알키닐기이거나, 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기이며, 인접한 X와 축합 고리를 형성할 수 있으며, Ar2 및 Ar3은 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기일 수 있다.R of an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, a cycloalkyl group, a heterocycloalkyl group, an arylamine group, an alkylsilyl group, an alkylboron group, an arylboron group, an aryl group Phosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryl Amine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkylboron group, C 6 ~ C 60 aryl boron group, C 6 ~ C substituted with at least 60 of the aryl phosphine group, C 6 ~ C 60 mono or diaryl phosphine blood group and a C 6 ~ selected from the group consisting arylsilyl of C 60 one kind of substituent or being unsubstituted , when substituted with a plurality of substituents, they may be the same or different from each other, m is an integer from 0 to 3, and when Ar1 is a plurality, they are the same or different from each other, and are each independently substituted or unsubstituted alkyl, A substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group, which may form a condensed ring with adjacent X, Ar2 and Ar3 may be the same as or different from each other, and may each independently be a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group.

구체적으로, 상기 화학식 2로 표시되는 화합물은 화학식5 내지 화학식 10 중 어느 하나로 표시될 수 있다.Specifically, the compound represented by Formula 2 may be represented by any one of Formulas 5 to 10.

[화학식 5][Formula 5]

Figure pat00007
Figure pat00007

[화학식 6][Formula 6]

Figure pat00008
Figure pat00008

[화학식 7][Formula 7]

Figure pat00009
Figure pat00009

[화학식 8][Formula 8]

Figure pat00010
Figure pat00010

[화학식 9][Formula 9]

Figure pat00011
Figure pat00011

[화학식10][Formula 10]

Figure pat00012
Figure pat00012

상기 화학식 5 내지 화학식 10에서, *는 결합이 이루어지는 부분이고, Y는 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, Z는 S 또는 O이고,In Formulas 5 to 10, * is a portion to which a bond is formed, Y is hydrogen, deuterium, halogen, cyano group, nitro group, C1-C40 alkyl group, C2-C4 0 alkenyl group, C 2 to C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 6 ~ C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 1 ~ C 40 alkyl Oxy group, C 6 ~ C 60 Aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 Arylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 60 Aryl boron group, C 6 ~ C 60 aryl phosphine group, is selected from the group consisting of an aryl amine of the C 6 ~ C 60 mono or diaryl phosphine blood group and a C 6 ~ C 60 of, Z is S or O,

X 및 Ar1은 각각 화학식 1에서 정의된 바와 같다.X and Ar1 are each as defined in Formula 1;

또한, 상기 화학식 3으로 표시되는 화합물은 화학식 11로 표시될 수 있다.In addition, the compound represented by Formula 3 may be represented by Formula 11.

[화학식 11][Formula 11]

Figure pat00013
Figure pat00013

상기 화학식 11에서, *는 결합이 이루어지는 부분이고, X는 화학식 1에서 정의된 바와 같다.In Formula 11, * is a moiety to which a bond is formed, and X is as defined in Formula 1.

또한, 상기 화학식 4로 표시되는 화합물은 화학식 12 또는 화학식 13으로 표시될 수 있다.In addition, the compound represented by Formula 4 may be represented by Formula 12 or Formula 13.

[화학식 12][Formula 12]

Figure pat00014
Figure pat00014

[화학식 13][Formula 13]

Figure pat00015
Figure pat00015

상기 화학식 12 또는 화학식 13에서, *는 결합이 이루어지는 부분이고, X는 화학식 1에서 정의된 바와 같다.In Formula 12 or Formula 13, * is a moiety to which a bond is formed, and X is as defined in Formula 1.

구체적으로, 상기 화학식 5는 하기 화학식 14 또는 화학식 15로 구체화될 수 있다.Specifically, Formula 5 may be embodied as Formula 14 or Formula 15 below.

[화학식 14][Formula 14]

Figure pat00016
Figure pat00016

[화학식 15][Formula 15]

Figure pat00017
Figure pat00017

상기 화학식 14 또는 화학식 15에서, *는 결합이 이루어지는 부분이고, Ar1은 화학식 1에서 정의된 바와 같다.In Formula 14 or Formula 15, * is a moiety to which a bond is formed, and Ar1 is as defined in Formula 1.

구체적으로, 상기 화학식 6는 하기 화학식 16로 구체화될 수 있다.Specifically, Formula 6 may be embodied as Formula 16 below.

[화학식 16][Formula 16]

Figure pat00018
Figure pat00018

상기 화학식 16에서, *는 결합이 이루어지는 부분이고, Ar1은 화학식 1에서 정의된 바와 같다.In Formula 16, * is a moiety to which a bond is formed, and Ar1 is as defined in Formula 1.

구체적으로, 상기 화학식 12는 하기 화학식 17로 구체화될 수 있다.Specifically, Chemical Formula 12 may be embodied as Chemical Formula 17 below.

[화학식 17][Formula 17]

Figure pat00019
Figure pat00019

상기 화학식 17에서, *는 결합이 이루어지는 부분이다.In Formula 17, * is a moiety to which a bond is formed.

상기 L은 단일결합이거나, 하기 L-1 내지 L-3 중에서 선택되는 링커일 수 있다.The L may be a single bond or a linker selected from the following L-1 to L-3.

Figure pat00020
Figure pat00021
Figure pat00022
Figure pat00020
Figure pat00021
Figure pat00022

L-1 내지 L-3에서, *는 결합이 이루어지는 부분이다.In L-1 to L-3, * is a moiety to which a bond is formed.

이상에서 설명한 본 발명의 일례에 따른 화학식 1로 표시되는 화합물은 하기 예시된 화합물로 이루어진 군에서 선택되는 어느 하나로 표시되는 화합물로 보다 구체화될 수 있다. 그러나 본 발명의 화학식 1로 표시되는 화합물이 하기 예시된 것들에 의해 한정되는 것은 아니다.The compound represented by Formula 1 according to an example of the present invention described above may be further specified as a compound represented by any one selected from the group consisting of the compounds exemplified below. However, the compound represented by Formula 1 of the present invention is not limited by those exemplified below.

Figure pat00023
Figure pat00023

Figure pat00024
Figure pat00024

Figure pat00025
Figure pat00025

Figure pat00026
Figure pat00026

Figure pat00027
Figure pat00027

Figure pat00028
Figure pat00028

Figure pat00029
Figure pat00029

Figure pat00030
Figure pat00030

Figure pat00031
Figure pat00031

Figure pat00032
Figure pat00032

Figure pat00033
Figure pat00033

Figure pat00034
Figure pat00034

Figure pat00035
Figure pat00035

Figure pat00036
Figure pat00036

Figure pat00037
Figure pat00037

Figure pat00038
Figure pat00038

Figure pat00039
Figure pat00039

Figure pat00040
Figure pat00040

본 발명에서 "알킬"은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkyl" refers to a monovalent substituent derived from a linear or branched saturated hydrocarbon having 1 to 40 carbon atoms. Examples thereof include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl, and the like.

본 발명에서 "알케닐(alkenyl)"은 탄소-탄소 이중 결합을 1개 이상 가진탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, “alkenyl” refers to a monovalent substituent derived from a linear or branched unsaturated hydrocarbon having 2 to 40 carbon atoms and having one or more carbon-carbon double bonds. Examples thereof include, but are not limited to, vinyl, allyl, isopropenyl, 2-butenyl, and the like.

본 발명에서 "알키닐(alkynyl)"은 탄소-탄소 삼중 결합을 1개 이상 가진탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 에티닐(ethynyl), 2-프로파닐(2-propynyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkynyl" refers to a monovalent substituent derived from a straight or branched unsaturated hydrocarbon having 2 to 40 carbon atoms and having one or more carbon-carbon triple bonds. Examples thereof include, but are not limited to, ethynyl, 2-propynyl, and the like.

본 발명에서 "아릴"은 단독 고리 또는 2이상의 고리가 조합된 탄소수 6 내지 40의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있다. 이러한 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "aryl" refers to a monovalent substituent derived from an aromatic hydrocarbon having 6 to 40 carbon atoms in which a single ring or two or more rings are combined. In addition, two or more rings may be simply attached to each other (pendant) or condensed form may be included. Examples of such aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.

본 발명에서 "헤테로아릴"은 핵원자수 5 내지 40의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이때, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있고, 나아가 아릴기와의 축합된 형태도 포함될 수 있다. 이러한 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리, 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리 및 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "heteroaryl" refers to a monovalent substituent derived from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 40 nuclear atoms. In this case, one or more carbons in the ring, preferably 1 to 3 carbons, are substituted with a heteroatom such as N, O, S or Se. In addition, a form in which two or more rings are simply attached to each other or condensed may be included, and further, a form condensed with an aryl group may be included. Examples of such heteroaryl include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, phenoxathienyl, indolizinyl, indolyl ( polycyclic rings such as indolyl), purinyl, quinolyl, benzothiazole, and carbazolyl, and 2-furanyl, N-imidazolyl, 2-isoxazolyl , 2-pyridinyl, 2-pyrimidinyl, and the like, but is not limited thereto.

본 발명에서 "아릴옥시"는 RO-로 표시되는 1가의 치환기로, 상기 R은 탄소수 5 내지 40의 아릴을 의미한다. 이러한 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "aryloxy" is a monovalent substituent represented by RO-, wherein R means aryl having 5 to 40 carbon atoms. Examples of such aryloxy include, but are not limited to, phenyloxy, naphthyloxy, diphenyloxy, and the like.

본 발명에서 "알킬옥시"는 R'O-로 표시되는 1가의 치환기로, 상기 R'는 탄소수 1 내지 40의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함할 수 있다. 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkyloxy" is a monovalent substituent represented by R'O-, wherein R' means an alkyl having 1 to 40 carbon atoms, and has a linear, branched or cyclic structure. may include Examples of alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy, and the like.

본 발명에서 "아릴아민"은 탄소수 6 내지 40의 아릴로 치환된 아민을 의미한다.In the present invention, "arylamine" refers to an amine substituted with an aryl having 6 to 40 carbon atoms.

본 발명에서 "시클로알킬"은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 노르보닐(norbornyl), 아다만틴(adamantine) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "cycloalkyl" means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms. Examples of such cycloalkyl include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.

본 발명에서 "헤테로시클로알킬"은 핵원자수 3 내지 40의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로 원자로 치환된다. 이러한 헤테로시클로알킬의 예로는 모르폴린, 피페라진 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "heterocycloalkyl" means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, and at least one carbon in the ring, preferably 1 to 3 carbons, is N, O, S or a hetero atom such as Se. Examples of such heterocycloalkyl include, but are not limited to, morpholine and piperazine.

본 발명에서 "알킬실릴"은 탄소수 1 내지 40의 알킬로 치환된 실릴이고, "아릴실릴"은 탄소수 5 내지 40의 아릴로 치환된 실릴을 의미한다.In the present invention, "alkylsilyl" refers to silyl substituted with alkyl having 1 to 40 carbon atoms, and "arylsilyl" refers to silyl substituted with aryl having 5 to 40 carbon atoms.

본 발명에서 "축합고리"는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.In the present invention, "condensed ring" means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.

2. 전자수송층2. Electron transport layer

본 발명에 따라 화학식 1으로 표시되는 화합물은, 융합된 플루오렌을 코어(core)로 채택하고, 상기 코어 구조의 페닐기에 전자 수송능이 뛰어난 전자끄는기(electron withdrawing group: EWG)가 결합되어 전자를 받는 특성이 강하므로, 상기 화학식 1의 화합물을 전자수송층으로 적용시, 음극으로부터 전자를 잘 수용할 수 있으므로, 발광층으로 전자를 원활히 전달할 수 있다. 따라서, 본 발명은 상기 화학식 1로 표시되는 전자수송층용 화합물로 사용될 수 있다.According to the present invention, the compound represented by Formula 1 adopts fused fluorene as a core, and an electron withdrawing group (EWG) having excellent electron transport ability is bonded to the phenyl group of the core structure to release electrons Since the receiving property is strong, when the compound of Formula 1 is applied as an electron transport layer, electrons can be well received from the cathode, and thus electrons can be smoothly transferred to the light emitting layer. Therefore, the present invention can be used as the compound for the electron transport layer represented by the formula (1).

전자수송층(ETL)은 음극에서 전자를 받아 발광층으로 전자를 이동시키는 역할을 한다. 이에 따라, 전자수송층에 사용되는 재료는 전자를 받는 특성이 강할수록, 전자를 이동시키는데 적합하다.The electron transport layer (ETL) serves to receive electrons from the cathode and move the electrons to the light emitting layer. Accordingly, the stronger the material used for the electron transport layer, the more suitable it is to move electrons.

구체적으로, 상기 전자수송층(ETL)은 음극에서 주입되는 전자를 인접하는 층, 구체적으로 발광층으로 이동시키는 역할을 하며, 상기 화학식 1로 표시되는 화합물은 전자수송층(ETL) 재료로서 단독으로 사용될 수 있으며, 또는 당 분야에 공지된 전자수송층 재료와 혼용될 수 있다.Specifically, the electron transport layer (ETL) serves to move electrons injected from the cathode to an adjacent layer, specifically, a light emitting layer, and the compound represented by Formula 1 may be used alone as an electron transport layer (ETL) material. , or may be mixed with an electron transport layer material known in the art.

상기 화학식 1의 화합물과 혼용될 수 있는 전자수송층 재료는, 당 분야에서 통상적으로 공지된 전자수송 물질을 포함하며, 사용 가능한 전자 수송 물질의 비제한적인 예로는 옥사졸계 화합물, 이소옥사졸계 화합물, 트리아졸계 화합물, 이소티아졸(isothiazole)계 화합물, 옥사디아졸계 화합물, 티아다아졸(thiadiazole)계 화합물, 페릴렌(perylene)계 화합물, 알루미늄 착물(예: Alq3 (트리스(8-퀴놀리놀라토)-알루미늄(tris(8-quinolinolato)-aluminium) BAlq, SAlq, Almq3, 갈륨 착물(예: Gaq'2OPiv, Gaq'2OAc, 2(Gaq'2)) 등이 있다. 이들을 단독으로 사용하거나 또는 2종 이상 혼용할 수 있다.The electron transport layer material that can be mixed with the compound of Formula 1 includes an electron transport material commonly known in the art, and non-limiting examples of the electron transport material that can be used include an oxazole-based compound, an isoxazole-based compound, and a tria. Sol-based compounds, isothiazole-based compounds, oxadiazole-based compounds, thiadiazole-based compounds, perylene-based compounds, aluminum complexes (eg, Alq3 (tris(8-quinolinolato) -aluminum (tris(8-quinolinolato)-aluminium) BAlq, SAlq, Almq3, gallium complex (eg Gaq'2OPiv, Gaq'2OAc, 2(Gaq'2)), etc. These may be used alone or in two types more can be mixed.

본 발명에서, 상기 화학식 1의 화합물과 전자수송층 재료를 혼용할 경우, 이들의 혼합 비율은 특별히 제한되지 않으며, 당 분야에 공지된 범위 내에서 적절히 조절될 수 있다.In the present invention, when the compound of Formula 1 and the electron transport layer material are mixed, their mixing ratio is not particularly limited and may be appropriately adjusted within a range known in the art.

3. 유기 전계 발광 소자3. Organic electroluminescent device

한편, 본 발명의 다른 측면은 상기한 본 발명에 따른 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자(유기 EL 소자)에 관한 것이다.Meanwhile, another aspect of the present invention relates to an organic electroluminescent device (organic EL device) including the compound represented by Formula 1 according to the present invention.

구체적으로, 본 발명은 양극(anode), 음극(cathode), 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함한다. 이때, 상기 화합물은 단독 또는 2종 이상 혼합되어 사용될 수 있다.Specifically, the present invention is an organic electroluminescent device comprising an anode, a cathode, and one or more organic material layers interposed between the anode and the cathode, wherein at least one of the one or more organic material layers is and a compound represented by Formula 1 above. In this case, the compound may be used alone or in mixture of two or more.

상기 1층 이상의 유기물층은 정공 주입층, 정공 수송층, 발광층, 발광 보조층, 전자 수송층, 전자 수송 보조층 및 전자 주입층 중 어느 하나 이상일 수 있고, 이 중에서 적어도 하나의 유기물층은 상기 화학식 1로 표시되는 화합물을 포함한다. 구체적으로 상기 화학식 1의 화합물을 포함하는 유기물층은 발광층, 전자수송층, 전자수송 보조층인 것이 바람직하다.The one or more organic material layers may be any one or more of a hole injection layer, a hole transport layer, a light emitting layer, a light emission auxiliary layer, an electron transport layer, an electron transport auxiliary layer, and an electron injection layer, and at least one organic material layer is represented by Formula 1 including compounds. Specifically, it is preferable that the organic material layer including the compound of Formula 1 is a light emitting layer, an electron transport layer, and an electron transport auxiliary layer.

본 발명에 따른 유기 전계 발광 소자의 발광층은 호스트 재료와 도펀트 재료를 포함하는데, 이때 호스트 재료로서 상기 화학식 1의 화합물을 포함할 수 있다. 또한 본 발명의 발광층은 상기 화학식 1의 화합물 이외의 당 분야의 공지된 화합물을 호스트로서 포함할 수 있다.The light emitting layer of the organic electroluminescent device according to the present invention includes a host material and a dopant material, and in this case, the compound of Formula 1 may be included as the host material. In addition, the light emitting layer of the present invention may include a known compound in the art other than the compound of Formula 1 as a host.

상기 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 발광층 재료, 바람직하게는 청색, 녹색, 적색의 인광 호스트 재료로 포함할 경우, 발광층에서 정공과 전자의 결합력이 높아지기 때문에, 유기 전계 발광 소자의 효율(발광효율 및 전력효율), 수명, 휘도 및 구동전압 등을 향상시킬 수 있다. 구체적으로 상기 화학식 1로 표시되는 화합물은 녹색 및/또는 적색의 인광 호스트, 형광 호스트, 또는 도펀트 재료로서 유기 전계 발광 소자에 포함되는 것이 바람직하다. 특히, 본 발명의 화학식 1로 표시되는 화합물은 고효율을 가진 발광층의 그린 인광 exciplex N-type 호스트 재료인 것이 바람직하다.When the compound represented by Formula 1 is included as a light emitting layer material of an organic electroluminescent device, preferably a blue, green, or red phosphorescent host material, since the bonding force between holes and electrons in the light emitting layer is increased, the efficiency of the organic electroluminescent device (luminous efficiency and power efficiency), lifespan, luminance, and driving voltage can be improved. Specifically, the compound represented by Formula 1 is preferably included in the organic electroluminescent device as a green and/or red phosphorescent host, a fluorescent host, or a dopant material. In particular, the compound represented by Formula 1 of the present invention is preferably a green phosphorescent exciplex N-type host material of the light emitting layer having high efficiency.

이러한 본 발명의 유기 전계 발광 소자의 구조는 특별히 한정되지 않으나, 기판, 양극, 정공주입층, 정공수송층, 발광보조층, 발광층, 전자수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 이때, 상기 정공주입층, 정공수송층, 발광보조층, 발광층, 전자수송층 및 전자주입층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있고, 바람직하게는 발광층, 보다 바람직하게는 인광 호스트가 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 한편 상기 전자수송층 위에는 전자주입층이 추가로 적층될 수 있다.The structure of the organic electroluminescent device of the present invention is not particularly limited, but may be a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting auxiliary layer, a light emitting layer, an electron transport layer and a cathode are sequentially stacked. At this time, at least one of the hole injection layer, the hole transport layer, the light emitting auxiliary layer, the light emitting layer, the electron transport layer and the electron injection layer may include the compound represented by Formula 1, preferably the light emitting layer, more preferably a phosphorescent host may include a compound represented by Formula 1 above. Meanwhile, an electron injection layer may be additionally stacked on the electron transport layer.

본 발명의 유기 전계 발광 소자의 구조는 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수 있다.The structure of the organic electroluminescent device of the present invention may be a structure in which an insulating layer or an adhesive layer is inserted at the interface between the electrode and the organic material layer.

본 발명의 유기 전계 발광 소자는, 전술한 유기물층 중 1층 이상이 상기 화학식 1로 표시되는 화합물을 포함하는 것을 제외하고는, 당 업계에 공지된 재료 및 방법으로 유기물층 및 전극을 형성하여 제조할 수 있다.The organic electroluminescent device of the present invention can be manufactured by forming an organic material layer and an electrode using materials and methods known in the art, except that at least one layer of the organic material layer includes the compound represented by Formula 1 above. have.

상기 유기물층은 진공 증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이에 한정되지는 않는다.The organic material layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer method.

본 발명의 유기 전계 발광 소자 제조시 사용되는 기판은 특별히 한정되지 않으며, 일례로 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 및 시트 등을 사용할 수 있다.The substrate used in manufacturing the organic electroluminescent device of the present invention is not particularly limited, and for example, a silicon wafer, quartz, a glass plate, a metal plate, a plastic film, and a sheet may be used.

또, 양극 물질은 당 분야에 공지된 양극 물질을 제한 없이 사용할 수 있다. 일례를 들면, 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등을 들 수 있으나, 이에 한정되지는 않는다.In addition, as the cathode material, a cathode material known in the art may be used without limitation. For example, metals such as vanadium, chromium, copper, zinc, gold, or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO2:Sb; conductive polymers such as polythiophene, poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene](PEDT), polypyrrole or polyaniline; and carbon black, but is not limited thereto.

또, 음극 물질은 당 분야에 공지된 음극 물질을 제한 없이 사용할 수 있다. 일례를 들면, 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등을 들 수 있으나, 이에 한정되지는 않는다.In addition, as the negative electrode material, any negative electrode material known in the art may be used without limitation. For example, a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or an alloy thereof; and a multilayer structure material such as LiF/Al or LiO2/Al, but is not limited thereto.

또한, 정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층은 특별히 한정되는 것은 아니며, 당 업계에 공지된 통상의 물질을 제한 없이 사용할 수 있다.In addition, the hole injection layer, the hole transport layer, the electron injection layer and the electron transport layer are not particularly limited, and conventional materials known in the art may be used without limitation.

이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail through examples. However, the following examples only illustrate the present invention, and the present invention is not limited by the following examples.

[준비예 1] 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine의 합성[Preparation Example 1] Synthesis of 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine

Figure pat00041
Figure pat00041

6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 2-chloropyridine (13g, 114.53 mmol)및 Pd(OAc)2 (1.17 g, 5.21 mmol), CS2CO3 ( 101.55g, 312.36mmol), XPhos (9.8 g, 20.82 mmol)을 THF 1000ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine (32.34 g, 수율 72%)을 얻었다.6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 2-chloropyridine (13 g, 114.53 mmol) and Pd(OAc) ) 2 (1.17 g, 5.21 mmol), CS 2 CO 3 ( 101.55 g, 312.36 mmol), and XPhos (9.8 g, 20.82 mmol) were added to 1000 ml of THF and 250 ml of H 2 O , and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl was ) pyridine (32.34 g, yield 72%) was obtained.

1H-NMR: δ 1.20(s, 12H), 6.90(t, 1H), 8.37(d, 1H), 7.38(t, 1H), 7.14(d, 1H), 8.14(d, 1H), 7.62(t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s, 1H), 8.76(s, 1H), 8.98(d, 1H), 7.68(t, 1H), 7.62(t, 1H), 8.11(d, 1H) 1 H-NMR: δ 1.20 (s, 12H), 6.90 (t, 1H), 8.37 (d, 1H), 7.38 (t, 1H), 7.14 (d, 1H), 8.14 (d, 1H), 7.62 ( t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s, 1H), 8.76(s, 1H), 8.98(d, 1H), 7.68(t, 1H), 7.62(t) , 1H), 8.11 (d, 1H)

[LCMS] : 431 [LCMS]: 431

위의 합성방법과 마찬가지로, 2-chloropyridine 대신, 3-chloropyridine 혹은 4-chloropyridine를 사용하면 아래 구조와 같이 각각 3-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine, 3-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine을 얻을 수 있다.As in the above synthesis method, if 3-chloropyridine or 4-chloropyridine is used instead of 2-chloropyridine, 3-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan) is used as shown in the following structure, respectively. Obtain -2-yl)chrysen-6-yl)pyridine, 3-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine can

Figure pat00042
Figure pat00043
Figure pat00042
Figure pat00043

[준비예 2] 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)benzonitrile의 합성[Preparation Example 2] Synthesis of 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)benzonitrile

Figure pat00044
Figure pat00044

6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 4-chlorobenzonitrile (15.76g, 114.53 mmol)및 Pd(OAc)2 (1.17 g, 5.21 mmol), CS2CO3 ( 101.55g, 312.36mmol), XPhos (9.8 g, 20.82 mmol)을 THF 1000ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)benzonitrile (34.14 g, 수율 72%)을 얻었다.6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 4-chlorobenzonitrile (15.76 g, 114.53 mmol) and Pd ( OAc) 2 (1.17 g, 5.21 mmol), CS 2 CO 3 ( 101.55 g, 312.36 mmol), and XPhos (9.8 g, 20.82 mmol) were added to 1000 ml of THF and 250 ml of H 2 O , and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound, 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl), was used by column chromatography. ) benzonitrile (34.14 g, yield 72%) was obtained.

1H-NMR: δ 1.20(s, 12H), 6.90(t, 1H), 8.35(d, 1H), 8.37(d, 1H), 8.25(d, 1H), 8.34(d, 1H), 7.62(t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s, 1H), 8.76(s, 1H), 8.98(d, 1H), 7.68(t, 1H), 7.62(t, 1H), 8.11(d, 1H) 1 H-NMR: δ 1.20 (s, 12H), 6.90 (t, 1H), 8.35 (d, 1H), 8.37 (d, 1H), 8.25 (d, 1H), 8.34 (d, 1H), 7.62 ( t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s, 1H), 8.76(s, 1H), 8.98(d, 1H), 7.68(t, 1H), 7.62(t) , 1H), 8.11 (d, 1H)

[LCMS] : 455 [LCMS]: 455

[준비예 3] 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline의 합성[Preparation Example 3] Synthesis of 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline

Figure pat00045
Figure pat00045

6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 8-chloroquinoline (18.74g, 114.53 mmol)및 Pd(OAc)2 (1.17 g, 5.21 mmol), CS2CO3 ( 101.55g, 312.36mmol), XPhos (9.8 g, 20.82 mmol)을 THF 1000ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline (36.09 g, 수율 72%)을 얻었다.6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 8-chloroquinoline (18.74 g, 114.53 mmol) and Pd ( OAc) 2 (1.17 g, 5.21 mmol), CS 2 CO 3 ( 101.55 g, 312.36 mmol), and XPhos (9.8 g, 20.82 mmol) were added to 1000 ml of THF and 250 ml of H 2 O , and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl ) quinoline (36.09 g, yield 72%) was obtained.

1H-NMR: δ 1.20(s, 12H), 6.90(t, 1H), 8.35(d, 1H), 8.37(t, 1H), 8.25(d, 1H), 8.34(d, 1H), 8.24(t, 1H), 8.27(d, 1H), 7.62(t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s, 1H), 8.76(s, 1H), 8.98(d, 1H), 7.68(t, 1H), 7.62(t, 1H), 8.11(d, 1H) 1 H-NMR: δ 1.20 (s, 12H), 6.90 (t, 1H), 8.35 (d, 1H), 8.37 (t, 1H), 8.25 (d, 1H), 8.34 (d, 1H), 8.24 ( t, 1H), 8.27(d, 1H), 7.62(t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s, 1H), 8.76(s, 1H), 8.98(d) , 1H), 7.68 (t, 1H), 7.62 (t, 1H), 8.11 (d, 1H)

[LCMS] : 481 [LCMS]: 481

위의 합성방법과 마찬가지로, 8-chloroquinoline 대신, 5-chloroquinoline를 사용하면 아래 구조와 같이 5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline을 얻을 수 있다.As in the above synthesis method, if 5-chloroquinoline is used instead of 8-chloroquinoline, 5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) chrysen-6-yl)quinoline can be obtained.

Figure pat00046
Figure pat00046

[준비예 4] 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile의 합성[Preparation Example 4] 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene- Synthesis of 2-carbonitrile

Figure pat00047
Figure pat00047

6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 7-chloro-9,9-dimethyl-9H-fluorene-2-carbonitrile (29.06g, 114.53 mmol)및 Pd(OAc)2 (1.17 g, 5.21 mmol), CS2CO3 ( 101.55g, 312.36mmol), XPhos (9.8 g, 20.82 mmol)을 THF 1000ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile (42.85 g, 수율 72%)을 얻었다.6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 7-chloro-9,9-dimethyl-9H-fluorene -2-carbonitrile (29.06 g, 114.53 mmol) and Pd(OAc) 2 (1.17 g, 5.21 mmol), CS 2 CO 3 ( 101.55 g, 312.36 mmol), XPhos (9.8 g, 20.82 mmol) in 1000 ml of THF, H 2 O It was put into 250ml and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) was used by column chromatography. ) chrysen-6-yl)-9H-fluorene-2-carbonitrile (42.85 g, yield 72%) was obtained.

1H-NMR: δ 1.20(s, 12H), 1.30(s, 6H), 6.90(t, 1H), 8.33(s, 1H), 8.37(d, 1H), 8.35(d, 1H), 8.34(d, 1H), 8.24(d, 1H), 8.26(s, 1H), 7.62(t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s, 1H), 8.76(s, 1H), 8.98(d, 1H), 7.68(t, 1H), 7.62(t, 1H), 8.11(d, 1H) 1 H-NMR: δ 1.20 (s, 12H), 1.30 (s, 6H), 6.90 (t, 1H), 8.33 (s, 1H), 8.37 (d, 1H), 8.35 (d, 1H), 8.34 ( d, 1H), 8.24(d, 1H), 8.26(s, 1H), 7.62(t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s, 1H), 8.76(s) , 1H), 8.98 (d, 1H), 7.68 (t, 1H), 7.62 (t, 1H), 8.11 (d, 1H)

[LCMS] : 571 [LCMS]: 571

위의 합성방법과 마찬가지로, 7-chloro-9,9-dimethyl-9H-fluorene-2-carbonitrile 대신 5-chloro-9,9-dimethyl-9H-fluorene-2-carbonitrile 를 사용하면 아래 구조와 같이 9,9-dimethyl-5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile을 얻을 수 있다.As in the above synthesis method, if 5-chloro-9,9-dimethyl-9H-fluorene-2-carbonitrile is used instead of 7-chloro-9,9-dimethyl-9H-fluorene-2-carbonitrile, 9 to obtain ,9-dimethyl-5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile have.

Figure pat00048
Figure pat00048

[준비예 5] 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile의 합성[Preparation Example 5] 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene ] Synthesis of -2'-carbonitrile

Figure pat00049
Figure pat00049

6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 2'-chlorospiro[cyclohexane-1,9'-fluorene]-7'-carbonitrile (33.65g, 114.53 mmol)및 Pd(OAc)2 (1.17 g, 5.21 mmol), CS2CO3 ( 101.55g, 312.36mmol), XPhos (9.8 g, 20.82 mmol)을 THF 1000ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile (45.85 g, 수율 72%)을 얻었다.6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 2'-chlorospiro[cyclohexane-1,9'-fluorene ]-7'-carbonitrile (33.65 g, 114.53 mmol) and Pd(OAc) 2 (1.17 g, 5.21 mmol), CS 2 CO 3 ( 101.55 g, 312.36 mmol), XPhos (9.8 g, 20.82 mmol) in 1000 ml of THF , put into 250ml of H2O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6- yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile (45.85 g, yield 72%) was obtained.

1H-NMR: δ 1.20(s, 12H), 1.30(s, 4H), 1.33(s, 4H), 1.35(s, 2H), 6.90(t, 1H), 8.33(s, 1H), 8.37(d, 1H), 8.35(d, 1H), 8.34(d, 1H), 8.24(d, 1H), 8.26(s, 1H), 7.62(t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s, 1H), 8.76(s, 1H), 8.98(d, 1H), 7.68(t, 1H), 7.62(t, 1H), 8.11(d, 1H) 1 H-NMR: δ 1.20(s, 12H), 1.30(s, 4H), 1.33(s, 4H), 1.35(s, 2H), 6.90(t, 1H), 8.33(s, 1H), 8.37( d, 1H), 8.35 (d, 1H), 8.34 (d, 1H), 8.24 (d, 1H), 8.26 (s, 1H), 7.62 (t, 1H), 7.70 (t, 1H), 9.08 (d) , 1H), 8.27(s, 1H), 8.76(s, 1H), 8.98(d, 1H), 7.68(t, 1H), 7.62(t, 1H), 8.11(d, 1H)

[LCMS] : 611 [LCMS]: 611

위의 합성방법과 마찬가지로, 2'-chlorospiro[cyclohexane-1,9'-fluorene]-7'-carbonitrile 대신 5'-chlorospiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile 를 사용하면 아래 구조와 같이 5'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile을 얻을 수 있다.As in the above synthesis method, if 5'-chlorospiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile is used instead of 2'-chlorospiro[cyclohexane-1,9'-fluorene]-7'-carbonitrile, 5'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]- 2'-carbonitrile can be obtained.

Figure pat00050
Figure pat00050

[준비예 6] 4'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-3,2':6',3''-terpyridine의 합성[Preparation Example 6] 4'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-3,2':6',3 Synthesis of ''-terpyridine

Figure pat00051
Figure pat00051

6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 4'-chloro-3,2':6',3''-terpyridine (30.66g, 114.53 mmol)및 Pd(OAc)2 (1.17 g, 5.21 mmol), CS2CO3 ( 101.55g, 312.36mmol), XPhos (9.8 g, 20.82 mmol)을 THF 1000ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 4'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-3,2':6',3''-terpyridine (43.89 g, 수율 72%)을 얻었다.6,12-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysene (50.0 g, 104.12 mmol), 4'-chloro-3,2':6', 3''-terpyridine (30.66 g, 114.53 mmol) and Pd(OAc) 2 (1.17 g, 5.21 mmol), CS 2 CO 3 ( 101.55 g, 312.36 mmol), XPhos (9.8 g, 20.82 mmol) in 1000 ml of THF, It was put into 250ml of H2O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 4'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6- yl)-3,2':6',3''-terpyridine (43.89 g, yield 72%) was obtained.

1H-NMR: δ 1.20(s, 12H), 7.90(t, 1H), 8.32(s, 1H), 8.37(s, 1H), 8.35(s, 1H), 8.34(s, 1H), 8.24(d, 1H), 8.26(t, 1H), 8.27(d, 2H), 8.29(d, 2H), 7.62(t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s, 1H), 8.76(s, 1H), 8.98(d, 1H), 7.68(t, 1H), 7.62(t, 1H), 8.11(d, 1H) 1 H-NMR: δ 1.20(s, 12H), 7.90(t, 1H), 8.32(s, 1H), 8.37(s, 1H), 8.35(s, 1H), 8.34(s, 1H), 8.24( d, 1H), 8.26(t, 1H), 8.27(d, 2H), 8.29(d, 2H), 7.62(t, 1H), 7.70(t, 1H), 9.08(d, 1H), 8.27(s) , 1H), 8.76(s, 1H), 8.98(d, 1H), 7.68(t, 1H), 7.62(t, 1H), 8.11(d, 1H)

[LCMS] : 585 [LCMS]: 585

* 합성예* Synthesis example

[합성예 1] 화합물 A-1의 합성[Synthesis Example 1] Synthesis of compound A-1

Figure pat00052
Figure pat00052

준비예의 목적 화합물 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine (10g, 23.18mmol)와 2-chloro-4,6-diphenyl-1,3,5-triazine (6.21 g, 23.18 mmol) 및 Pd(PPh3)4 (1.34 g, 1.16 mmol), K2CO3 (9.61 g, 69.55 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-1 (8.96g, 수율 72 %)을 얻었다.The target compound of the preparation example 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine (10g, 23.18mmol) and 2-chloro- 4,6-diphenyl-1,3,5-triazine (6.21 g, 23.18 mmol) and Pd(PPh 3 ) 4 (1.34 g, 1.16 mmol), K 2 CO 3 (9.61 g, 69.55 mmol) in 200 ml of THF, It was put into 50ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-1 (8.96 g, yield 72%) was obtained by column chromatography.

[LCMS] : 536[LCMS]: 536

위와 같은 합성 방법으로 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine 대신 3-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine 혹은 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine을 사용하면 각각 목적 화합물인 A-3, A-5을 얻을 수 있다.Using the above synthesis method, 3-(12-(4,4) instead of 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine ,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine or 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan) If -2-yl)chrysen-6-yl)pyridine is used, the target compounds A-3 and A-5 can be obtained, respectively.

또한 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine과 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine 대신 3-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine 혹은 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine을 사용하면 예시구조의 A-11,13,15, A-21,23,25, A-31,33,35, A-41,43,45, A-51,53,55, A-61,63,65를 얻을 수 있으며, 2-chloro-4,6-diphenyl-1,3,5-triazine혹은 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 에 각각 Para 방향의 Phenyl이 추가된 Linker를 사용하여 B-1,3,5, B-11,13,15, B-21,23,25, B-31,33,35, B-41,43,45, B-51,53,55, B-61,63,65을 얻을 수 있으며 Meta 방향의 Phenyl이 추가된 Linker를 사용하면 C-1,3,5, C-11,13,15, C-21,23,25, C-31,33,35, C-41,43,45, C-51,53,55, C-61,63,65을 얻을 수 있다.Also, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine, 4-chloro-2,6-diphenylpyrimidine or 2-chloro-3,5,6-triphenylpyrazine or 4-([1,1'- biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine or 2-chloro-4-(dibenzo[b ,d]furan-3-yl)-6-phenyl-1,3,5-triazine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3 3-(12-(4,4) instead of 5-triazine and 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine ,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine or 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan) If -2-yl)chrysen-6-yl)pyridine is used, A-11,13,15, A-21,23,25, A-31,33,35, A-41,43,45, A-51,53,55, A-61,63,65 can be obtained, 2-chloro-4,6-diphenyl-1,3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 2- chloro-3,5,6-triphenylpyrazine or 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 4-chloro-6-(dibenzo[b,d]furan- 3-yl)-2-phenylpyrimidine or 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine or 2-([1,1'- biphenyl]-4-yl)-4-chloro-6-phenyl-1 ,B-1,3,5, B-11,13,15, B-21,23,25, B-31,33,35 using a linker with Para-direction added to ,3,5-triazine. , B-41,43,45, B-51,53,55, B-61,63,65 can be obtained, and C-1,3,5, C-11 when using a linker with added phenyl in the meta direction ,13,15, C-21,23,25, C-31,33,35, C-41,43,45, C-51,53,55, C-61,63,65 can be obtained.

[합성예 2] 화합물 A-2의 합성[Synthesis Example 2] Synthesis of compound A-2

Figure pat00053
Figure pat00053

준비예의 목적 화합물 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)benzonitrile (10g, 21.96mmol)와 2-chloro-4,6-diphenyl-1,3,5-triazine (5.88 g, 21.96 mmol) 및 Pd(PPh3)4 (1.27 g, 1.10 mmol), K2CO3 (9.11 g, 65.88 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-2 (8.86g, 수율 72 %)을 얻었다.The target compound of the preparation example 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)benzonitrile (10g, 21.96mmol) and 2-chloro- 4,6-diphenyl-1,3,5-triazine (5.88 g, 21.96 mmol) and Pd(PPh 3 ) 4 (1.27 g, 1.10 mmol), K 2 CO 3 (9.11 g, 65.88 mmol) in 200 ml of THF, It was put into 50ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-2 (8.86 g, yield 72%) was obtained by column chromatography.

[LCMS] : 560[LCMS] : 560

또한, 위와 같은 합성방법으로 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine을 사용하면 예시구조의 A-12,22,32,42,52,62를 얻을 수 있으며, 2-chloro-4,6-diphenyl-1,3,5-triazine혹은 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 에 각각 Para 방향의 Phenyl이 추가된 Linker를 사용하여 B-2,12,22,32,42,52,62을 얻을 수 있으며 Meta 방향의 Phenyl이 추가된 Linker를 사용하면 C-2,12,22,32,42,52,62를 얻을 수 있다.In addition, by the above synthesis method, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine, 4-chloro-2,6-diphenylpyrimidine or 2-chloro-3,5,6-triphenylpyrazine or 4-( [1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine or 2-chloro- 4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6 If -phenyl-1,3,5-triazine is used, A-12,22,32,42,52,62 of the exemplary structure can be obtained, and 2-chloro-4,6-diphenyl-1,3,5- triazine or 4-chloro-2,6-diphenylpyrimidine or 2-chloro-3,5,6-triphenylpyrazine or 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 4 -chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine or 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3 ,5-triazine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine by using a linker with Para-direction Phenyl added B-2,12,22,32,42,52,62 can be obtained, and C-2,12,22,32,42,52,62 can be obtained by using a linker with added phenyl in the meta direction.

[합성예 3] 화합물 A-4의 합성[Synthesis Example 3] Synthesis of compound A-4

Figure pat00054
Figure pat00054

준비예의 목적 화합물 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline (10g, 20.77mmol)와 2-chloro-4,6-diphenyl-1,3,5-triazine (5.56 g, 20.77 mmol) 및 Pd(PPh3)4 (1.20 g, 1.04 mmol), K2CO3 (8.61 g, 62.32 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-4 (8.77g, 수율 72 %)을 얻었다.The target compound of the preparation example 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline (10g, 20.77mmol) and 2-chloro- 4,6-diphenyl-1,3,5-triazine (5.56 g, 20.77 mmol) and Pd(PPh 3 ) 4 (1.20 g, 1.04 mmol), K 2 CO 3 (8.61 g, 62.32 mmol) in 200 ml of THF, It was put into 50ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-4 (8.77 g, yield 72%) was obtained by column chromatography.

[LCMS] : 586[LCMS]: 586

위와 같은 합성 방법으로 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline 대신 5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline 을 사용하면 각각 목적 화합물인 A-6을 얻을 수 있다.5-(12-(4,4) instead of 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline by the above synthesis method If ,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline is used, the target compound, A-6, can be obtained, respectively.

또한 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine과 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline 대신 5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline 을 사용하면 예시구조의 A-14,16,24,26,34,36,44,46,54,56,64,66을 얻을 수 있으며, 2-chloro-4,6-diphenyl-1,3,5-triazine혹은 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 에 각각 Para 방향의 Phenyl이 추가된 Linker를 사용하여 B-14,16,24,26,34,36,44,46,54,56,64,66을 얻을 수 있으며 Meta 방향의 Phenyl이 추가된 Linker를 사용하면 C-14,16,24,26,34,36,44,46,54,56,64,66을 얻을 수 있다.Also, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine, 4-chloro-2,6-diphenylpyrimidine or 2-chloro-3,5,6-triphenylpyrazine or 4-([1,1'- biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine or 2-chloro-4-(dibenzo[b ,d]furan-3-yl)-6-phenyl-1,3,5-triazine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3 5-(12-(4,4) instead of 5-triazine and 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline When using ,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline, A-14,16,24,26,34,36,44,46, 54,56,64,66 can be obtained, 2-chloro-4,6-diphenyl-1,3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 2-chloro-3,5,6- triphenylpyrazine or 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine or 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine or 2-([1,1'-biphenyl]-4-yl)- B-14,16,24,26,34,36,44,46,54,56; You can get 64,66 and Meta C-14,16,24,26,34,36,44,46,54,56,64,66 can be obtained by using a linker with added phenyl of the direction.

[합성예 4] 화합물 A-7의 합성[Synthesis Example 4] Synthesis of compound A-7

Figure pat00055
Figure pat00055

준비예의 목적 화합물 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile (10g, 17.50mmol)와 2-chloro-4,6-diphenyl-1,3,5-triazine (4.68 g, 17.50 mmol) 및 Pd(PPh3)4 (1.01 g, 0.87 mmol), K2CO3 (7.25 g, 52.49 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-7 (8.53g, 수율 72 %)을 얻었다.Target compound of the preparation example 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2 -carbonitrile (10 g, 17.50 mmol) with 2-chloro-4,6-diphenyl-1,3,5-triazine (4.68 g, 17.50 mmol) and Pd(PPh 3 ) 4 (1.01 g, 0.87 mmol), K 2 CO 3 (7.25 g, 52.49 mmol) was added to 200 ml of THF and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-7 (8.53 g, yield 72%) was obtained by column chromatography.

[LCMS] : 676[LCMS]: 676

위와 같은 합성 방법으로 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile 대신 9,9-dimethyl-5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile 을 사용하면 각각 목적 화합물인 A-8을 얻을 수 있다.9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene- 9,9-dimethyl-5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2 instead of 2-carbonitrile If -carbonitrile is used, the target compound, A-8, can be obtained.

또한 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine과 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile 대신 9,9-dimethyl-5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile을 사용하면 예시구조의 A-17,18,27,28,37,38,47,48,57,58,67,68 을 얻을 수 있으며, 2-chloro-4,6-diphenyl-1,3,5-triazine혹은 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 에 각각 Para 방향의 Phenyl이 추가된 Linker를 사용하여 B-17,18,27,28,37,38,47,48,57,58,67,68 을 얻을 수 있으며 Meta 방향의 Phenyl이 추가된 Linker를 사용하면 C-17,18,27,28,37,38,47,48,57,58,67,68 을 얻을 수 있다.Also, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine, 4-chloro-2,6-diphenylpyrimidine or 2-chloro-3,5,6-triphenylpyrazine or 4-([1,1'- biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine or 2-chloro-4-(dibenzo[b ,d]furan-3-yl)-6-phenyl-1,3,5-triazine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3 ,5-triazine and 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene- 9,9-dimethyl-5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2 instead of 2-carbonitrile If you use -carbonitrile, you can get A-17,18,27,28,37,38,47,48,57,58,67,68 of the example structure, 2-chloro-4,6-diphenyl-1, 3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 2-chloro-3,5,6-triphenylpyrazine or 4-([1,1'-biphenyl]-4-yl)-6-chloro-2 -phenylpyrimidine or 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine or 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl -1,3,5-triazine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine with Para-direction Phenyl added Link B-17,18,27,28,37,38,47,48,57,58,67,68 can be obtained by using er, and C-17,18, 27,28,37,38,47,48,57,58,67,68 can be obtained.

[합성예 5] 화합물 A-9의 합성[Synthesis Example 5] Synthesis of compound A-9

Figure pat00056
Figure pat00056

준비예의 목적 화합물 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile (10g, 16.35mmol)와 2-chloro-4,6-diphenyl-1,3,5-triazine (4.38 g, 16.35 mmol) 및 Pd(PPh3)4 (0.94 g, 0.82 mmol), K2CO3 (6.78 g, 49.05 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-9 (8.44g, 수율 72 %)을 얻었다.Target compound of the preparation example 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene] -2'-carbonitrile (10 g, 16.35 mmol) with 2-chloro-4,6-diphenyl-1,3,5-triazine (4.38 g, 16.35 mmol) and Pd(PPh 3 ) 4 (0.94 g, 0.82 mmol) , K 2 CO 3 (6.78 g, 49.05 mmol) was placed in 200 ml of THF and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-9 (8.44 g, yield 72%) was obtained by column chromatography.

[LCMS] : 716[LCMS] : 716

위와 같은 합성 방법으로 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile 대신 5'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile 을 사용하면 각각 목적 화합물인 A-10을 얻을 수 있다.7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene 5'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9' instead of ]-2'-carbonitrile -fluorene]-2'-carbonitrile can be used to obtain A-10, the target compound, respectively.

또한 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine과 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile 대신 5'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile 을 사용하면 예시구조의 A-19,20,29,30,39,40,49,50,59,60,69,70 을 얻을 수 있으며, 2-chloro-4,6-diphenyl-1,3,5-triazine혹은 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 에 각각 Para 방향의 Phenyl이 추가된 Linker를 사용하여 B-19,20,29,30,39,40,49,50,59,60,69,70 을 얻을 수 있으며 Meta 방향의 Phenyl이 추가된 Linker를 사용하면 C-19,20,29,30,39,40,49,50,59,60,69,70 을 얻을 수 있다.Also, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine, 4-chloro-2,6-diphenylpyrimidine or 2-chloro-3,5,6-triphenylpyrazine or 4-([1,1'- biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine or 2-chloro-4-(dibenzo[b ,d]furan-3-yl)-6-phenyl-1,3,5-triazine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3 ,5-triazine and 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene 5'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9' instead of ]-2'-carbonitrile -fluorene]-2'-carbonitrile can be used to obtain A-19,20,29,30,39,40,49,50,59,60,69,70 of the example structure, 2-chloro-4, 6-diphenyl-1,3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 2-chloro-3,5,6-triphenylpyrazine or 4-([1,1'-biphenyl]-4-yl) -6-chloro-2-phenylpyrimidine or 4-chloro-6-(dibenzo[b,d]furan-3-yl)-2-phenylpyrimidine or 2-chloro-4-(dibenzo[b,d]furan-3- Para to yl)-6-phenyl-1,3,5-triazine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine, respectively room B-19,20,29,30,39,40,49,50,59,60,69,70 can be obtained by using a linker with added phenyl in the direction of meta. C-19,20,29,30,39,40,49,50,59,60,69,70 can be obtained.

[합성예 6] 화합물 D-1의 합성[Synthesis Example 6] Synthesis of compound D-1

Figure pat00057
Figure pat00057

준비예의 목적 화합물 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine (10g, 23.18mmol)와 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine (6.88 g, 23.18 mmol) 및 Pd(PPh3)4 (1.34 g, 1.16 mmol), K2CO3 (9.61 g, 69.55 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 D-1 (9.44g, 수율 72 %)을 얻었다.The target compound of the preparation example 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine (10g, 23.18mmol) and 4-chloro- 2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine (6.88 g, 23.18 mmol) and Pd(PPh 3 ) 4 (1.34 g, 1.16 mmol), K 2 CO 3 (9.61 g, 69.55 mmol) was placed in 200 ml of THF and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound D-1 (9.44 g, yield 72%) was obtained by column chromatography.

[LCMS] : 565[LCMS]: 565

위와 같은 합성 방법으로 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine 대신 3-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine 혹은 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine을 사용하면 각각 목적 화합물인 D-3, D-5을 얻을 수 있다.Using the above synthesis method, 3-(12-(4,4) instead of 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine ,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine or 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan) If -2-yl)chrysen-6-yl)pyridine is used, the target compounds D-3 and D-5 can be obtained, respectively.

또한 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 대신 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine 과 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine 대신 3-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine 혹은 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine 을 사용하면 예시구조의 D-11,13,15, D-21,23,25, D-31,33,35, D-41,43,45, D-51,53,55, D-61,63,65를 얻을 수 있으며, 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 대신 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine 에 각각 Para 방향의 Phenyl이 추가된 Linker를 사용하여 E-1,3,5, E-11,13,15, E-21,23,25, E-31,33,35, E-41,43,45, E-51,53,55, E-61,63,65을 얻을 수 있으며 Meta 방향의 Phenyl이 추가된 Linker를 사용하면 F-1,3,5, F-11,13,15, F-21,23,25, F-31,33,35, F-41,43,45, F-51,53,55, F-61,63,65을 얻을 수 있다.Also, instead of 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine, 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine or 2-chloro-6,8-diphenyl-[ 1,2,4]triazolo[1,5-a]pyridine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine or 2-chloro-4-phenylbenzofuro[2,3- d]pyrimidine and 2-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine instead of 3-(12-(4,4, 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)pyridine or 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-) If 2-yl)chrysen-6-yl)pyridine is used, D-11,13,15, D-21,23,25, D-31,33,35, D-41,43,45, D -51,53,55, D-61,63,65 can be obtained, and 4-chloro-2-phenylbenzofuro[3 instead of 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine ,2-d]pyrimidine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 2-chloro-4-phenylbenzo[4,5]thieno[2, E-1,3,5, E-11,13,15, E-1,3,5, E-11,13,15, using a linker with Para-direction Phenyl added to 3-d]pyrimidine or 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine E-21,23,25, E-31,33,35, E-41,43,45, E-51,53,55, E-61,63,65 can be obtained, With Linker, F- 1,3,5, F-11,13,15, F-21,23,25, F-31,33,35, F-41,43,45, F-51,53,55, F-61, 63,65 can be obtained.

[합성예 7] 화합물 D-2의 합성[Synthesis Example 7] Synthesis of compound D-2

Figure pat00058
Figure pat00058

준비예의 목적 화합물 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)benzonitrile (10g, 21.96mmol)와 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine (6.52 g, 21.96 mmol) 및 Pd(PPh3)4 (1.27 g, 1.10 mmol), K2CO3 (9.11 g, 65.88 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 D-2 (9.32g, 수율 72 %)을 얻었다.The target compound of the preparation example 4-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)benzonitrile (10g, 21.96mmol) and 4-chloro- 2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine (6.52 g, 21.96 mmol) and Pd(PPh 3 ) 4 (1.27 g, 1.10 mmol), K 2 CO 3 (9.11 g, 65.88 mmol) was placed in 200 ml of THF and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound D-2 (9.32 g, yield 72%) was obtained by column chromatography.

[LCMS] : 589[LCMS]: 589

또한, 위와 같은 합성방법으로 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 대신 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine 을 사용하면 예시구조의 D-12,22,32,42,52,62를 얻을 수 있으며, 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 대신 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine 에 각각 Para 방향의 Phenyl이 추가된 Linker를 사용하여 E-2,12,22,32,42,52,62을 얻을 수 있으며 Meta 방향의 Phenyl이 추가된 Linker를 사용하면 F-2,12,22,32,42,52,62를 얻을 수 있다.In addition, instead of 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine, 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine or 2-chloro-6 ,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine or 2-chloro-4- Using phenylbenzofuro[2,3-d]pyrimidine, D-12,22,32,42,52,62 of the exemplary structure can be obtained, and 4-chloro-2-phenylbenzo[4,5]thieno[3,2 Instead of -d]pyrimidine, 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 2- E- using a linker in which phenyl in the Para direction is added to chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine or 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine, respectively. 2,12,22,32,42,52,62 can be obtained, and F-2,12,22,32,42,52,62 can be obtained by using a linker with added phenyl in the meta direction.

[합성예 8] 화합물 D-4의 합성[Synthesis Example 8] Synthesis of compound D-4

Figure pat00059
Figure pat00059

준비예의 목적 화합물 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline (10g, 20.77mmol)와 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine (6.16 g, 20.77 mmol) 및 Pd(PPh3)4 (1.20 g, 1.04 mmol), K2CO3 (8.61 g, 62.32 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 D-4 (9.21g, 수율 72 %)을 얻었다.The target compound of the preparation example 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline (10g, 20.77mmol) and 4-chloro- 2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine (6.16 g, 20.77 mmol) and Pd(PPh 3 ) 4 (1.20 g, 1.04 mmol), K 2 CO 3 (8.61 g, 62.32 mmol) was placed in 200 ml of THF and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound D-4 (9.21 g, yield 72%) was obtained by column chromatography.

[LCMS] : 586[LCMS]: 586

위와 같은 합성 방법으로 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline 대신 5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline 을 사용하면 각각 목적 화합물인 D-6을 얻을 수 있다.5-(12-(4,4) instead of 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline by the above synthesis method If ,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline is used, the target compound, D-6, can be obtained, respectively.

또한 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 대신 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine 과 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline 대신 5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline 을 사용하면 예시구조의 D-14,16,24,26,34,36,44,46,54,56,64,66을 얻을 수 있으며, 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 대신 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine 에 각각 Para 방향의 Phenyl이 추가된 Linker를 사용하여 E-14,16,24,26,34,36,44,46,54,56,64,66을 얻을 수 있으며 Meta 방향의 Phenyl이 추가된 Linker를 사용하면 F-14,16,24,26,34,36,44,46,54,56,64,66을 얻을 수 있다.Also, instead of 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine, 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine or 2-chloro-6,8-diphenyl-[ 1,2,4]triazolo[1,5-a]pyridine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine or 2-chloro-4-phenylbenzofuro[2,3- d]pyrimidine and 8-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline instead of 5-(12-(4,4, When using 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)quinoline, D-14,16,24,26,34,36,44,46,54 of the example structure ,56,64,66 can be obtained, and 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine or 2 instead of 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine -chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine or 2- E-14,16,24,26,34,36,44,46,54,56,64, E-14,16,24,26,34,36,44,46,54,56,64 using a linker with Para-direction added to chloro-4-phenylbenzofuro[2,3-d]pyrimidine 66 can be obtained, and F-14,16,24,26,34,36,44,46,54,56,64,66 can be obtained by using a linker with added phenyl in the meta direction.

[합성예 9] 화합물 D-7의 합성[Synthesis Example 9] Synthesis of compound D-7

Figure pat00060
Figure pat00060

준비예의 목적 화합물 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile (10g, 17.50mmol)와 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine (5.19 g, 17.50 mmol) 및 Pd(PPh3)4 (1.01 g, 0.87 mmol), K2CO3 (7.25 g, 52.49 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 D-7 (8.89g, 수율 72 %)을 얻었다.Target compound of the preparation example 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2 -carbonitrile (10 g, 17.50 mmol) with 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine (5.19 g, 17.50 mmol) and Pd(PPh 3 ) 4 (1.01 g, 0.87 mmol) ), K 2 CO 3 (7.25 g, 52.49 mmol) was added to 200 ml of THF and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound D-7 (8.89g, yield 72%) was obtained by column chromatography.

[LCMS] : 705[LCMS]: 705

위와 같은 합성 방법으로 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile 대신 9,9-dimethyl-5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile 을 사용하면 각각 목적 화합물인 D-8을 얻을 수 있다.9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene- 9,9-dimethyl-5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2 instead of 2-carbonitrile If -carbonitrile is used, the target compound, D-8, can be obtained.

또한 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 대신 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine 과 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile 대신 9,9-dimethyl-5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2-carbonitrile 을 사용하면 예시구조의 D-17,18,27,28,37,38,47,48,57,58,67,68 을 얻을 수 있으며, 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 대신 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine 에 각각 Para 방향의 Phenyl이 추가된 Linker를 사용하여 E-17,18,27,28,37,38,47,48,57,58,67,68 을 얻을 수 있으며 Meta 방향의 Phenyl이 추가된 Linker를 사용하면 F-17,18,27,28,37,38,47,48,57,58,67,68 을 얻을 수 있다.Also, instead of 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine, 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine or 2-chloro-6,8-diphenyl-[ 1,2,4]triazolo[1,5-a]pyridine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine or 2-chloro-4-phenylbenzofuro[2,3- d]pyrimidine and 9,9-dimethyl-7-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2 9,9-dimethyl-5-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-9H-fluorene-2- instead of -carbonitrile If carbonitrile is used, D-17,18,27,28,37,38,47,48,57,58,67,68 of the exemplary structure can be obtained, and 4-chloro-2-phenylbenzo[4,5]thieno 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a] instead of [3,2-d]pyrimidine Linker with Para-direction Phenyl added to pyridine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine or 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine, respectively. E-17,18,27,28,37,38,47,48,57,58,67,68 can be obtained by using the F-17,18,27, You can get 28,37,38,47,48,57,58,67,68.

[합성예 10] 화합물 D-9의 합성[Synthesis Example 10] Synthesis of compound D-9

Figure pat00061
Figure pat00061

준비예의 목적 화합물 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile (10g, 16.35mmol)와 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine (4.85 g, 16.35 mmol) 및 Pd(PPh3)4 (0.94 g, 0.82 mmol), K2CO3 (6.78 g, 49.05 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 D-9 (8.78g, 수율 72 %)을 얻었다.Target compound of the preparation example 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene] -2'-carbonitrile (10 g, 16.35 mmol) with 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine (4.85 g, 16.35 mmol) and Pd(PPh 3 ) 4 (0.94 g) , 0.82 mmol), K 2 CO 3 (6.78 g, 49.05 mmol) was added to 200 ml of THF and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound D-9 (8.78 g, yield 72%) was obtained by column chromatography.

[LCMS] : 745[LCMS] : 745

위와 같은 합성 방법으로 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile 대신 5'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile 을 사용하면 각각 목적 화합물인 D-10을 얻을 수 있다.7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene 5'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9' instead of ]-2'-carbonitrile -fluorene]-2'-carbonitrile can be used to obtain the target compound, D-10, respectively.

또한 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 대신 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine 과 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile 대신 5'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile 을 사용하면 예시구조의 D-19,20,29,30,39,40,49,50,59,60,69,70 을 얻을 수 있으며, 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 대신 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine 에 각각 Para 방향의 Phenyl이 추가된 Linker를 사용하여 E-19,20,29,30,39,40,49,50,59,60,69,70 을 얻을 수 있으며 Meta 방향의 Phenyl이 추가된 Linker를 사용하면 F-19,20,29,30,39,40,49,50,59,60,69,70 을 얻을 수 있다.Also, instead of 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine, 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine or 2-chloro-6,8-diphenyl-[ 1,2,4]triazolo[1,5-a]pyridine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine or 2-chloro-4-phenylbenzofuro[2,3- d]pyrimidine and 7'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'-fluorene] 5'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)spiro[cyclohexane-1,9'- instead of -2'-carbonitrile If fluorene]-2'-carbonitrile is used, D-19,20,29,30,39,40,49,50,59,60,69,70 of the exemplary structure can be obtained, and 4-chloro-2-phenylbenzo Instead of [4,5]thieno[3,2-d]pyrimidine, 4-chloro-2-phenylbenzofuro[3,2-d]pyrimidine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[ Para-direction to 1,5-a]pyridine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine or 2-chloro-4-phenylbenzofuro[2,3-d]pyrimidine, respectively E-19,20,29,30,39,40,49,50,59,60,69,70 can be obtained by using a phenyl-added linker, and F- 19,20,29,30,39,40,49,50,59,60,69,70 can be obtained.

[합성예 11] 화합물 G-1의 합성[Synthesis Example 11] Synthesis of compound G-1

Figure pat00062
Figure pat00062

준비예의 목적 화합물 4'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-3,2':6',3''-terpyridine (10g, 17.08mmol)와 2-chloro-4,6-diphenyl-1,3,5-triazine (4.57 g, 17.08 mmol) 및 Pd(PPh3)4 (0.99 g, 0.85 mmol), K2CO3 (7.08 g, 51.24 mmol)을 THF 200ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 G-1 (8.49g, 수율 72 %)을 얻었다.Target compound 4'-(12-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chrysen-6-yl)-3,2':6',3''-terpyridine (10 g, 17.08 mmol) with 2-chloro-4,6-diphenyl-1,3,5-triazine (4.57 g, 17.08 mmol) and Pd(PPh 3 ) 4 (0.99 g, 0.85 mmol), K 2 CO 3 (7.08 g, 51.24 mmol) was added to 200 ml of THF and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound G-1 (8.49 g, yield 72%) was obtained by column chromatography.

[LCMS] : 690[LCMS]: 690

또한 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine 혹은 4-(4-bromophenyl)-2,6-diphenylpyrimidine 혹은 2-(4-bromophenyl)-3,5,6-triphenylpyrazine 혹은 4-([1,1'-biphenyl]-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-(4-bromophenyl)-6-phenyl-1,3,5-triazine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 혹은 4-(4-bromophenyl)-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-(4-bromophenyl)-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine 를 사용하면 예시구조의 G-2~15를 얻을 수 있다.Also, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine, 4-chloro-2,6-diphenylpyrimidine or 2-chloro-3,5,6-triphenylpyrazine or 4-([1,1'- biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 2-chloro-4-(dibenzo[b,d]furan-3-yl)-6-phenyl-1,3,5-triazine or 4- (4-bromophenyl)-2,6-diphenylpyrimidine or 2-(4-bromophenyl)-3,5,6-triphenylpyrazine or 4-([1,1'-biphenyl]-4-yl)-6-(4- bromophenyl)-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-(4-bromophenyl)-6-phenyl-1,3,5-triazine or 4-chloro-2- phenylbenzo[4,5]thieno[3,2-d]pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine or 4-(4-bromophenyl)-2-phenylbenzo[ If 4,5]thieno[3,2-d]pyrimidine or 2-(4-bromophenyl)-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine is used, can get

* 소자예(소자평가 결과)* Device example (device evaluation result)

[실시예 1~26] 녹색 유기 EL 소자의 제작[Examples 1-26] Preparation of green organic EL device

화합물 A-2,12,22,32,42,52,62, B-2,12,22,32,42,52,62, D-2,12,22,33,42, E-2,12,22,32,42, G-1,2를 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 녹색 유기 EL 소자를 제작하였다.Compound A-2,12,22,32,42,52,62, B-2,12,22,32,42,52,62, D-2,12,22,33,42, E-2,12 ,22,32,42, G-1,2 was subjected to high-purity sublimation purification by a commonly known method, and then a green organic EL device was manufactured according to the following procedure.

먼저, ITO (Indium tin oxide)가 1500

Figure pat00063
두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, ITO (Indium tin oxide) is 1500
Figure pat00063
The thin film-coated glass substrate was washed with distilled water and ultrasonic waves. After washing with distilled water, it is ultrasonically cleaned with a solvent such as isopropyl alcohol, acetone, methanol, etc., dried, transferred to a UV OZONE cleaner (Power sonic 405, Hwashin Tech), and then the substrate is cleaned using UV for 5 minutes and vacuum evaporator The substrate was transferred to

이렇게 준비된 ITO 투명 전극 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ A-2,12,22,32,42,52,62, B-2,12,22,32,42,52,62, D-2,12,22,33,42, E-2,12,22,32,42, G-1,2의 각각의 화합물 + 10 % Ir(ppy)3 (30nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 EL 소자를 제작하였다. On the prepared ITO transparent electrode, m-MTDATA (60 nm)/TCTA (80 nm)/ A-2,12,22,32,42,52,62, B-2,12,22,32,42,52, 62, D-2,12,22,33,42, E-2,12,22,32,42, each compound of G-1,2 + 10% Ir(ppy) 3 (30 nm) / BCP (10 nm)/Alq 3 (30 nm)/LiF (1 nm)/Al (200 nm) were stacked in the order to fabricate an organic EL device.

m-MTDATA, TCTA, Ir(ppy)3, CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir(ppy) 3 , CBP and BCP are as follows.

Figure pat00064
Figure pat00064

Figure pat00065
Figure pat00065

[비교예1] 녹색 유기 EL 소자의 제작[Comparative Example 1] Fabrication of green organic EL device

발광층 형성시 발광 호스트 물질로서 화합물 A-2 대신 CBP를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 EL 소자를 제작하였다.A green organic EL device was manufactured in the same manner as in Example 1, except that CBP was used instead of Compound A-2 as a light emitting host material when the light emitting layer was formed.

[평가예1][Evaluation Example 1]

실시예 1 ~ 26 및 비교예 1에서 제작한 각각의 녹색 유기 EL 소자에 대하여 전류밀도 (10) mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.For each green organic EL device manufactured in Examples 1 to 26 and Comparative Example 1, the driving voltage, current efficiency, and emission peak at a current density of (10) mA/cm 2 were measured, and the results are shown in Table 1 below. it was

샘플Sample 호스트host 구동 전압
(V)
drive voltage
(V)
EL 피크
(nm)
EL peak
(nm)
전류효율
(cd/A)
current efficiency
(cd/A)
실시예 1Example 1 A-2A-2 5.435.43 515515 44.144.1 실시예 2Example 2 A-12A-12 5.525.52 516516 42.242.2 실시예 3Example 3 A-22A-22 5.445.44 516516 49.149.1 실시예 4Example 4 A-32A-32 5.545.54 517517 44.744.7 실시예 5Example 5 A-42A-42 5.345.34 517517 45.245.2 실시예 6Example 6 A-52A-52 5.685.68 516516 43.543.5 실시예 7Example 7 A-62A-62 5.435.43 515515 44.244.2 실시예 8Example 8 B-2B-2 5.555.55 517517 42.342.3 실시예 9Example 9 B-12B-12 5.435.43 518518 49.149.1 실시예 10Example 10 B-22B-22 5.535.53 517517 44.844.8 실시예 11Example 11 B-32B-32 5.355.35 517517 45.345.3 실시예 12Example 12 B-42B-42 5.695.69 516516 43.643.6 실시예 13Example 13 B-52B-52 5.435.43 515515 44.244.2 실시예 14Example 14 B-62B-62 5.525.52 516516 42.242.2 실시예 15Example 15 D-2D-2 5.345.34 517517 45.245.2 실시예 16Example 16 D-12D-12 5.645.64 516516 43.543.5 실시예 17Example 17 D-22D-22 5.435.43 515515 44.144.1 실시예 18Example 18 D-32D-32 5.695.69 516516 43.543.5 실시예 19Example 19 D-42D-42 5.435.43 515515 44.144.1 실시예 20Example 20 E-2E-2 5.435.43 515515 44.244.2 실시예 21Example 21 E-12E-12 5.505.50 516516 42.242.2 실시예 22Example 22 E-22E-22 5.445.44 516516 49.249.2 실시예 23Example 23 E-32E-32 5.355.35 518518 45.445.4 실시예 24Example 24 E-42E-42 5.695.69 516516 43.643.6 실시예 25Example 25 G-1G-1 5.435.43 515515 44.244.2 실시예 26Example 26 G-2G-2 5.555.55 516516 42.242.2 비교예 1Comparative Example 1 CBPCBP 6.526.52 516516 38.238.2

상기 표1에 나타낸 바와 같이, 본 발명에 따른 화합물 A-2,12,22,32,42,52,62, B-2,12,22,32,42,52,62, D-2,12,22,33,42, E-2,12,22,32,42, G-1,2를 녹색 유기 EL 소자의 발광층으로 사용하였을 경우(실시예 1~26) 종래 CBP를 사용한 녹색 유기 EL 소자(비교예1)와 비교해 볼 때 효율 및 구동전압 면에서 보다 우수한 성능을 나타내는 것을 알 수 있다.As shown in Table 1 above, compounds A-2,12,22,32,42,52,62, B-2,12,22,32,42,52,62, D-2,12 according to the present invention When ,22,33,42, E-2,12,22,32,42, G-1,2 were used as a light emitting layer of a green organic EL device (Examples 1-26), a green organic EL device using a conventional CBP It can be seen that when compared with (Comparative Example 1), it exhibits better performance in terms of efficiency and driving voltage.

[실시예 27~150] 청색 유기 전계 발광 소자의 제작[Examples 27-150] Fabrication of blue organic electroluminescent device

합성예 에서 합성된 화합물 A-3 ~ 73, B-3 ~ 69, D-3 ~ 39, E-3 ~ 39, G-1 ~ 14를 통상적으로 알려진 방법으로 고순도 승화정제를 한 후, 하기와 같이 청색 유기 전계 발광 소자를 제작하였다.Compounds A-3 to 73, B-3 to 69, D-3 to 39, E-3 to 39, and G-1 to 14 synthesized in Synthesis Example were subjected to high-purity sublimation purification by a conventionally known method, followed by Similarly, a blue organic electroluminescent device was fabricated.

먼저, ITO (Indium tin oxide)가 1500

Figure pat00066
두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면, 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후, UV OZONE 세정기(Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, ITO (Indium tin oxide) is 1500
Figure pat00066
The thin film-coated glass substrate was washed with distilled water and ultrasonic waves. After washing with distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc. The substrate was transferred to a vacuum evaporator.

상기와 같이 준비된 ITO 투명 전극 위에, DS-205 (㈜두산전자, 80 nm)/NPB (15 nm)/ADN + 5 % DS-405 (㈜두산전자, 30nm)/화합물 A-3 ~ 73, B-3 ~ 69, D-3 ~ 39, E-3 ~ 39, G-1 ~ 14각각의 화합물 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제작하였다. On the ITO transparent electrode prepared as above, DS-205 (Doosan Electronics, 80 nm)/NPB (15 nm)/ADN + 5 % DS-405 (Doosan Electronics, 30 nm)/Compounds A-3 to 73, B -3 ~ 69, D-3 ~ 39, E-3 ~ 39, G-1 ~ 14 Each compound (30 nm)/LiF (1 nm)/Al (200 nm) is laminated in order to form an organic electroluminescent device. produced.

[비교예 2] 청색 유기 전계 발광 소자의 제작[Comparative Example 2] Fabrication of a blue organic electroluminescent device

전자 수송층 물질로서 화합물 A-3 대신 Alq3을 사용하는 것을 제외하고는, 상기 실시예 27과 동일하게 수행하여 청색 유기 전계 발광 소자를 제작하였다.A blue organic electroluminescent device was manufactured in the same manner as in Example 27, except that Alq3 was used instead of Compound A-3 as the electron transport layer material.

[비교예 3] 청색 유기 전계 발광 소자의 제작[Comparative Example 3] Fabrication of a blue organic electroluminescent device

전자 수송층 물질로서 화합물 A-3을 사용하지 않은 것을 제외하고는, 상기 실시예 27과 동일하게 수행하여 청색 유기 전계 발광 소자를 제작하였다.A blue organic electroluminescent device was manufactured in the same manner as in Example 27, except that Compound A-3 was not used as the electron transport layer material.

상기 실시예 27 내지 150 및 비교예 2, 3에서 사용된 NPB, AND 및 Alq3의 구조는 하기와 같다. The structures of NPB, AND, and Alq3 used in Examples 27 to 150 and Comparative Examples 2 and 3 are as follows.

Figure pat00067
Figure pat00067

[평가예 2][Evaluation Example 2]

실시예 27 내지 150 및 비교예 2, 3에서 제작한 각각의 청색 유기 전계 발광 소자에 대하여 전류밀도 (10) mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하고, 그 결과를 하기 표 2에 나타내었다.For each of the blue organic electroluminescent devices manufactured in Examples 27 to 150 and Comparative Examples 2 and 3, the driving voltage, current efficiency, and emission peak at a current density (10) mA/cm 2 were measured, and the results are shown in the table below 2 is shown.

샘플Sample 재료material 구동 전압
(V)
drive voltage
(V)
EL 피크
(nm)
EL peak
(nm)
전류효율
(cd/A)
current efficiency
(cd/A)
실시예 27Example 27 A-3A-3 3.63.6 456456 6.66.6 실시예 28Example 28 A-4A-4 3.73.7 456456 6.56.5 실시예 29Example 29 A-6A-6 3.73.7 458458 6.66.6 실시예 30Example 30 A-7A-7 4.04.0 453453 6.56.5 실시예 31Example 31 A-8A-8 4.04.0 457457 6.56.5 실시예 32Example 32 A-9A-9 3.83.8 456456 6.86.8 실시예 33Example 33 A-10A-10 3.63.6 456456 6.66.6 실시예 34Example 34 A-13A-13 4.04.0 457457 6.56.5 실시예 35Example 35 A-14A-14 3.63.6 456456 6.66.6 실시예 36Example 36 A-16A-16 3.63.6 456456 6.66.6 실시예 37Example 37 A-17A-17 3.73.7 456456 6.56.5 실시예 38Example 38 A-18A-18 3.63.6 456456 6.66.6 실시예 39Example 39 A-19A-19 3.53.5 458458 6.66.6 실시예 40Example 40 A-20A-20 4.14.1 452452 6.56.5 실시예 41Example 41 A-23A-23 4.14.1 453453 6.56.5 실시예 42Example 42 A-24A-24 4.14.1 452452 6.56.5 실시예 43Example 43 A-26A-26 3.83.8 456456 6.86.8 실시예 44Example 44 A-27A-27 3.63.6 456456 6.66.6 실시예 45Example 45 A-28A-28 4.04.0 453453 6.56.5 실시예 46Example 46 A-29A-29 3.73.7 456456 6.56.5 실시예 47Example 47 A-30A-30 3.83.8 456456 6.76.7 실시예 48Example 48 A-33A-33 3.73.7 458458 6.66.6 실시예 49Example 49 A-34A-34 4.04.0 453453 6.56.5 실시예 50Example 50 A-36A-36 3.83.8 456456 6.76.7 실시예 51Example 51 A-37A-37 4.04.0 457457 6.66.6 실시예 52Example 52 A-38A-38 3.63.6 456456 6.66.6 실시예 53Example 53 A-39A-39 3.63.6 456456 6.66.6 실시예 54Example 54 A-40A-40 3.73.7 456456 6.86.8 실시예 55Example 55 A-43A-43 3.63.6 456456 6.66.6 실시예 56Example 56 A-44A-44 3.73.7 455455 6.56.5 실시예 57Example 57 A-46A-46 3.63.6 458458 6.66.6 실시예 58Example 58 A-47A-47 4.14.1 453453 6.56.5 실시예 59Example 59 A-48A-48 3.63.6 457457 6.66.6 실시예 60Example 60 A-49A-49 4.14.1 453453 6.56.5 실시예 61Example 61 A-50A-50 3.73.7 456456 6.86.8 실시예 62Example 62 A-53A-53 3.73.7 456456 6.86.8 실시예 63Example 63 A-54A-54 4.04.0 457457 6.66.6 실시예 64Example 64 A-56A-56 3.63.6 456456 6.66.6 실시예 65Example 65 A-57A-57 3.83.8 456456 6.86.8 실시예 66Example 66 A-58A-58 3.73.7 456456 6.96.9 실시예 67Example 67 A-59A-59 3.83.8 456456 6.86.8 실시예 68Example 68 A-60A-60 3.73.7 456456 6.66.6 실시예 69Example 69 A-63A-63 3.63.6 456456 6.66.6 실시예 70Example 70 A-64A-64 3.73.7 456456 6.66.6 실시예 71Example 71 A-66A-66 3.73.7 456456 6.56.5 실시예 72Example 72 A-67A-67 3.73.7 458458 6.76.7 실시예 73Example 73 A-68A-68 3.83.8 456456 6.86.8 실시예 74Example 74 A-69A-69 4.14.1 453453 6.56.5 실시예 75Example 75 A-70A-70 4.04.0 4545 6.66.6 실시예 76Example 76 B-3B-3 4.14.1 453453 6.56.5 실시예 77Example 77 B-4B-4 3.83.8 456456 6.86.8 실시예 78Example 78 B-6B-6 4.04.0 457457 6.66.6 실시예 79Example 79 B-7B-7 3.53.5 456456 6.66.6 실시예 80Example 80 B-9B-9 4.14.1 453453 6.56.5 실시예 81Example 81 B-13B-13 3.83.8 456456 6.86.8 실시예 82Example 82 B-14B-14 3.83.8 456456 6.86.8 실시예 83Example 83 B-16B-16 4.04.0 457457 6.66.6 실시예 84Example 84 B-17B-17 4.04.0 456456 6.66.6 실시예 85Example 85 B-19B-19 3.83.8 456456 6.86.8 실시예 86Example 86 B-23B-23 4.14.1 453453 6.56.5 실시예 87Example 87 B-24B-24 4.14.1 453453 6.56.5 실시예 88Example 88 B-26B-26 3.73.7 456456 6.76.7 실시예 89Example 89 B-27B-27 4.04.0 457457 6.66.6 실시예 90Example 90 B-29B-29 3.63.6 456456 6.66.6 실시예 91Example 91 B-33B-33 3.83.8 456456 6.86.8 실시예 92Example 92 B-34B-34 4.04.0 457457 6.66.6 실시예 93Example 93 B-36B-36 3.83.8 456456 6.86.8 실시예 94Example 94 B-37B-37 4.14.1 453453 6.56.5 실시예 95Example 95 B-39B-39 3.73.7 456456 6.86.8 실시예 96Example 96 B-43B-43 4.04.0 457457 6.66.6 실시예 97Example 97 B-44B-44 4.04.0 457457 6.66.6 실시예 98Example 98 B-46B-46 4.14.1 453453 6.66.6 실시예 99Example 99 B-47B-47 3.83.8 456456 6.86.8 실시예 100Example 100 B-49B-49 4.04.0 457457 6.66.6 실시예 101Example 101 B-53B-53 3.63.6 456456 6.66.6 실시예 102Example 102 B-54B-54 3.83.8 456456 6.86.8 실시예 103Example 103 B-56B-56 4.04.0 457457 6.66.6 실시예 104Example 104 B-57B-57 3.63.6 456456 6.66.6 실시예 105Example 105 B-59B-59 4.04.0 453453 6.56.5 실시예 106Example 106 B-63B-63 3.83.8 456456 6.86.8 실시예 107Example 107 B-64B-64 3.83.8 456456 6.76.7 실시예 108Example 108 B-66B-66 4.04.0 457457 6.66.6 실시예 109Example 109 B-67B-67 3.63.6 456456 6.66.6 실시예 110Example 110 B-69B-69 4.14.1 453453 6.56.5 실시예 111Example 111 D-3D-3 3.83.8 456456 6.86.8 실시예 112Example 112 D-4D-4 4.04.0 457457 6.66.6 실시예 113Example 113 D-6D-6 3.63.6 456456 6.66.6 실시예 114Example 114 D-7D-7 3.73.7 456456 6.56.5 실시예 115Example 115 D-9D-9 3.63.6 458458 6.66.6 실시예 116Example 116 D-23D-23 4.14.1 453453 6.56.5 실시예 117Example 117 D-24D-24 3.83.8 456456 6.86.8 실시예 118Example 118 D-26D-26 4.04.0 457457 6.66.6 실시예 119Example 119 D-27D-27 3.73.7 456456 6.56.5 실시예 120Example 120 D-29D-29 4.14.1 453453 6.66.6 실시예 121Example 121 D-33D-33 3.83.8 456456 6.86.8 실시예 122Example 122 D-34D-34 4.04.0 457457 6.66.6 실시예 123Example 123 D-36D-36 3.63.6 456456 6.66.6 실시예 124Example 124 D-37D-37 3.73.7 456456 6.66.6 실시예 125Example 125 D-39D-39 3.73.7 456456 6.56.5 실시예 126Example 126 E-3E-3 3.73.7 458458 6.66.6 실시예 127Example 127 E-4E-4 4.14.1 453453 6.56.5 실시예 128Example 128 E-6E-6 3.83.8 456456 6.86.8 실시예 129Example 129 E-7E-7 4.04.0 457457 6.66.6 실시예 130Example 130 E-9E-9 3.63.6 456456 6.66.6 실시예 131Example 131 E-23E-23 3.73.7 456456 6.56.5 실시예 132Example 132 E-24E-24 3.73.7 457457 6.66.6 실시예 133Example 133 E-26E-26 4.14.1 453453 6.56.5 실시예 134Example 134 E-27E-27 3.83.8 456456 6.66.6 실시예 135Example 135 E-29E-29 4.04.0 457457 6.66.6 실시예 136Example 136 E-33E-33 3.73.7 458458 6.66.6 실시예 137Example 137 E-34E-34 4.14.1 453453 6.56.5 실시예 138Example 138 E-36E-36 3.73.7 458458 6.66.6 실시예 140Example 140 E-37E-37 4.14.1 453453 6.56.5 실시예 141Example 141 E-39E-39 3.83.8 456456 6.86.8 실시예 142Example 142 G-1G-1 4.04.0 457457 6.66.6 실시예 143Example 143 G-2G-2 3.63.6 458458 6.66.6 실시예 144Example 144 G-4G-4 4.14.1 453453 6.56.5 실시예 145Example 145 G-5G-5 3.83.8 456456 6.86.8 실시예 146Example 146 G-7G-7 4.14.1 453453 6.56.5 실시예 147Example 147 G-8G-8 3.83.8 456456 6.76.7 실시예 148Example 148 G-9G-9 4.04.0 457457 6.66.6 실시예 149Example 149 G-13G-13 3.63.6 456456 6.66.6 실시예 150Example 150 G-14G-14 4.14.1 453453 6.56.5 비교예 2Comparative Example 2 Alq3 Alq 3 4.74.7 459459 5.65.6 비교예 3Comparative Example 3 -- 4.84.8 460460 6.26.2

상기 표 2에 나타낸 바와 같이, 본 발명의 화합물을 전자 수송층에 사용한 청색 유기 전계 발광 소자(실시예 27 내지 150)는 종래의 Alq3를 전자 수송층에 사용한 청색 유기 전계 발광 소자(비교예 2) 및 전자 수송층이 없는 청색 유기 전계 발광 소자(비교예 3)에 비해 구동전압, 발광피크 및 전류효율 면에서 우수한 성능을 나타내는 것을 알 수 있었다.As shown in Table 2, the blue organic electroluminescent device (Examples 27 to 150) using the compound of the present invention for the electron transport layer was a blue organic electroluminescent device using the conventional Alq3 for the electron transport layer (Comparative Example 2) and the electron It was found that the blue organic EL device without a transport layer (Comparative Example 3) exhibited superior performance in terms of driving voltage, emission peak and current efficiency.

[실시예 151~168] 청색 유기 전계 발광 소자의 제조 [Examples 151 to 168] Preparation of blue organic electroluminescent device

합성예 C-6~50, F-6~40에서 합성된 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후, 아래의 과정에 따라 청색 유기 전계 발광 소자를 제작하였다.After high-purity sublimation purification of the compounds synthesized in Synthesis Examples C-6 to 50 and F-6 to 40 by a commonly known method, a blue organic electroluminescent device was manufactured according to the following procedure.

ITO (Indium tin oxide)가 1500

Figure pat00068
두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면, 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후, UV OZONE 세정기(Power sonic 405, 화신테크)로 이송시킨 다음, UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.ITO (Indium tin oxide) is 1500
Figure pat00068
The thin film-coated glass substrate was washed with distilled water and ultrasonic waves. After washing with distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc. and transferred the substrate to a vacuum evaporator.

상기와 같이 준비된 ITO 투명 전극 위에, DS-205 (80 nm) / NPB (15 nm) / ADN + 5 % DS-405 (㈜두산전자, 30nm) / C-6~50, F-6~40 (5 nm) / Alq3 (25 nm) / LiF (1 nm) / Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다.On the ITO transparent electrode prepared as above, DS-205 (80 nm) / NPB (15 nm) / ADN + 5 % DS-405 (Doosan Electronics, 30 nm) / C-6~50, F-6~40 ( 5 nm) / Alq3 (25 nm) / LiF (1 nm) / Al (200 nm) were stacked in the order to prepare an organic electroluminescent device.

이때 사용된 NPB, ADN 및 Alq3의 구조는 다음과 같다.The structures of NPB, ADN and Alq3 used at this time are as follows.

Figure pat00069
Figure pat00069

[비교예 4] 청색 유기 전계 발광 소자의 제조[Comparative Example 4] Preparation of blue organic electroluminescent device

실시예 151에서 전자수송보조층 물질로 사용된 화합물 C-6을 사용하지 않고, 전자 수송층 물질인 Alq3를 25 nm 대신 30 nm로 증착하는 것을 제외하고는, 실시예 136과 동일하게 수행하여 청색 유기 전계 발광 소자를 제작하였다. In Example 151, the same procedure as in Example 136 was performed, except that compound C-6 used as an electron transport auxiliary layer material was not used, and Alq3, an electron transport layer material, was deposited at 30 nm instead of 25 nm. An electroluminescent device was fabricated.

[평가예 3][Evaluation Example 3]

실시예 151 내지 168 및 비교예 4에서 각각 제조된 유기 전계 발광 소자에 대하여, 전류밀도 10 mA/㎠에서의 구동전압, 발광파장, 전류효율, 발광파장을 측정하였고, 그 결과를 하기 표 3에 나타내었다.For the organic electroluminescent devices prepared in Examples 151 to 168 and Comparative Example 4, respectively, the driving voltage, emission wavelength, current efficiency, and emission wavelength at a current density of 10 mA/cm 2 were measured, and the results are shown in Table 3 below. indicated.

샘플Sample 전자수송보조층electron transport layer 구동 전압
(V)
drive voltage
(V)
발광 피크
(nm)
luminescence peak
(nm)
전류효율(cd/A)Current efficiency (cd/A)
실시예 151Example 151 C-6C-6 3.53.5 456456 6.76.7 실시예 152Example 152 C-8C-8 3.73.7 455455 6.56.5 실시예 153Example 153 C-10C-10 3.73.7 458458 6.66.6 실시예 154Example 154 C-36C-36 4.14.1 453453 6.56.5 실시예 155Example 155 C-38C-38 3.83.8 456456 6.86.8 실시예 156Example 156 C-40C-40 3.63.6 456456 6.56.5 실시예 157Example 157 C-46C-46 3.73.7 455455 6.56.5 실시예 158Example 158 C-48C-48 3.63.6 458458 6.66.6 실시예 159Example 159 C-50C-50 4.14.1 453453 6.56.5 실시예 160Example 160 F-6F-6 3.83.8 457457 6.86.8 실시예 161Example 161 F-8F-8 3.73.7 458458 6.56.5 실시예 162Example 162 F-10F-10 4.04.0 453453 6.56.5 실시예 163Example 163 F-26F-26 3.83.8 456456 6.86.8 실시예 164Example 164 F-28F-28 3.63.6 456456 6.66.6 실시예 165Example 165 F-30F-30 3.73.7 456456 6.76.7 실시예 166Example 166 F-36F-36 3.83.8 456456 6.86.8 실시예 167Example 167 F-38F-38 3.73.7 456456 6.56.5 실시예 168Example 168 F-40F-40 4.14.1 453453 6.56.5 비교예 4Comparative Example 4 -- 4.84.8 457457 5.85.8

표 3에 나타낸 바와 같이, 본 발명에 따른 화합물로 형성된 전자수송보조층을 포함하는 실시예 151 ~ 168의 청색 유기 전계 발광 소자는 전자수송보조층 없이 Alq3로 된 전자수송층을 포함하는 비교예 4의 유기 전계 발광 소자에 비해 전류 효율 및 구동전압 면에서 우수한 성능을 나타내는 것을 알 수 있었다.As shown in Table 3, the blue organic electroluminescent device of Examples 151 to 168 including an electron transport auxiliary layer formed of the compound according to the present invention is Comparative Example 4 comprising an electron transport layer made of Alq3 without an electron transport auxiliary layer It was found that the organic electroluminescent device exhibited superior performance in terms of current efficiency and driving voltage.

10: 양극 20: 음극
30: 유기층 31: 정공 수송층
32: 발광층 33: 정공 수송 보조층
34: 전자 수송층 35: 전자 수송 보조층
36: 전자 주입층 37: 정공 주입층
10: positive electrode 20: negative electrode
30: organic layer 31: hole transport layer
32: light emitting layer 33: hole transport auxiliary layer
34: electron transport layer 35: electron transport auxiliary layer
36: electron injection layer 37: hole injection layer

Claims (11)

하기 화학식 1로 표시되는 화합물:
[화학식 1]
Figure pat00070

상기 화학식 1에서,
L1 및 L2는 각각 독립적으로 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18개의 헤테로아릴렌기로 이루어진 군에서 선택되며,
n 은 0 내지 3의 정수이며,
상기 A 및 B는 각각 독립적으로 하기 화학식 2 내지 화학식 4 중 어느 하나로 표시되는 치환기이며,
[화학식 2]
Figure pat00071

[화학식 3]
Figure pat00072

[화학식 4]
Figure pat00073


상기 화학식 2 내지 화학식 4에서,
*는 결합이 이루어지는 부분이고,
복수의 X는 서로 동일하거나 상이하고, 각각 독립적으로 C(R) 또는 N이나, B로 표시되는 화학식 2 및 화학식 3에 의한 X는 적어도 둘 이상이 N이며,
R은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 서로 인접하는 기와 지방족, 방향족, 지방족헤테로 또는 방향족헤테로의 축합 고리를 형성하거나 스피로 결합을 이룰 수 있고,
상기 R의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있으며,
m 은 0 내지 3의 정수이며,
Ar1이 복수인 경우, 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 알킬이거나, 치환 또는 비치환된 알케닐기이거나, 치환 또는 비치환된 알키닐기이거나, 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기이며, 인접한 X와 축합 고리를 형성할 수 있으며,
Ar2 및 Ar3은 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기이다.
A compound represented by the following formula (1):
[Formula 1]
Figure pat00070

In Formula 1,
L1 and L2 are each independently a single bond, or C 6 ~ C 18 is selected from the group consisting of an arylene group and a heteroarylene group having 5 to 18 nuclear atoms,
n is an integer from 0 to 3,
A and B are each independently a substituent represented by any one of the following Chemical Formulas 2 to 4,
[Formula 2]
Figure pat00071

[Formula 3]
Figure pat00072

[Formula 4]
Figure pat00073


In Formulas 2 to 4,
* is the part where the bond is made,
A plurality of Xs are the same as or different from each other, and each independently C (R) or N, but X by Formula 2 and Formula 3 represented by B is at least two or more N,
R is hydrogen, deuterium, halogen, cyano group, nitro group, C1~ C40 alkyl group, C2~ C4 0 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 nuclear atoms to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 Arylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 60 Aryl boron group, C 6 ~ C 60 Arylphosphine group, C 6 ~ mono or diaryl phosphine of C 60 blood group and a C 6 ~ C is selected from the 60 group consisting of aryl amines, form a condensed ring of the group aliphatic, aromatic, aliphatic hetero, or aromatic heterocyclic group which are adjacent to each other, or to achieve a spiro bond there is,
R of an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, a cycloalkyl group, a heterocycloalkyl group, an arylamine group, an alkylsilyl group, an alkylboron group, an arylboron group, an aryl group Phosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryl Amine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkylboron group, C 6 ~ C 60 aryl boron group, C 6 ~ C substituted with at least 60 of the aryl phosphine group, C 6 ~ C 60 mono or diaryl phosphine blood group and a C 6 ~ selected from the group consisting arylsilyl of C 60 one kind of substituent or being unsubstituted , when substituted with a plurality of substituents, they may be the same or different from each other,
m is an integer from 0 to 3,
When Ar1 is plural, the same or different from each other, and each independently is a substituted or unsubstituted alkyl, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted aryl group, It is a substituted or unsubstituted heteroaryl group, and may form a condensed ring with adjacent X,
Ar2 and Ar3 are the same as or different from each other, and each independently represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group.
제1항에 있어서,
상기 화학식 2는 화학식5 내지 화학식 10으로 이루어진 군으로부터 선택되는 것을 특징으로 하는 화합물:
[화학식 5]
Figure pat00074

[화학식 6]
Figure pat00075

[화학식 7]
Figure pat00076

[화학식 8]
Figure pat00077

[화학식 9]
Figure pat00078

[화학식10]
Figure pat00079

상기 화학식 5 내지 화학식 10에서,
*는 결합이 이루어지는 부분이고,
Y는 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고,
Z는 S 또는 O이고,
X 및 Ar1은 각각 청구항 1에서 정의된 바와 같다.
According to claim 1,
Formula 2 is a compound, characterized in that selected from the group consisting of Formulas 5 to 10:
[Formula 5]
Figure pat00074

[Formula 6]
Figure pat00075

[Formula 7]
Figure pat00076

[Formula 8]
Figure pat00077

[Formula 9]
Figure pat00078

[Formula 10]
Figure pat00079

In Formulas 5 to 10,
* is the part where the bond is made,
Y is hydrogen, deuterium, halogen, cyano group, nitro group, C1~ C40 alkyl group, C2~ C4 0 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 nuclear atoms to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 Arylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 60 Aryl boron group, C 6 ~ C 60 Arylphosphine group, C 6 ~ of C 60 mono or diaryl phosphine group P is selected from the group consisting of C 6 ~ C 60 aryl amine,
Z is S or O;
X and Ar1 are each as defined in claim 1.
제1항에 있어서,
상기 화학식 3은 화학식 11인 것을 특징으로 하는 화합물:
[화학식 11]
Figure pat00080

상기 화학식 11에서,
*는 결합이 이루어지는 부분이고,
X는 청구항 1에서 정의된 바와 같다.
According to claim 1,
Formula 3 is a compound characterized in that the formula 11:
[Formula 11]
Figure pat00080

In the above formula (11),
* is the part where the bond is made,
X is as defined in claim 1.
제1항에 있어서,
상기 화학식 4은 화학식 12 또는 화학식 13인 것을 특징으로 하는 화합물:
[화학식 12]
Figure pat00081

[화학식 13]
Figure pat00082

상기 화학식 12 또는 화학식 13에서,
*는 결합이 이루어지는 부분이고,
X는 청구항 1에서 정의된 바와 같다.
According to claim 1,
Formula 4 is a compound characterized in that it is Formula 12 or Formula 13:
[Formula 12]
Figure pat00081

[Formula 13]
Figure pat00082

In Formula 12 or Formula 13,
* is the part where the bond is made,
X is as defined in claim 1.
제2항에 있어서,
상기 화학식 5는 하기 화학식 14 또는 화학식 15인 것을 특징으로 하는 화합물:
[화학식 14]
Figure pat00083

[화학식 15]
Figure pat00084

상기 화학식 13 또는 화학식 14에서,
*는 결합이 이루어지는 부분이고,
Ar1은 청구항 1에서 정의된 바와 같다.
3. The method of claim 2,
Formula 5 is a compound characterized in that it is represented by Formula 14 or Formula 15:
[Formula 14]
Figure pat00083

[Formula 15]
Figure pat00084

In Formula 13 or Formula 14,
* is the part where the bond is made,
Ar1 is as defined in claim 1.
제2항에 있어서,
상기 화학식 6은 하기 화학식 16인 것을 특징으로 하는 화합물:
[화학식 16]
Figure pat00085

상기 화학식 16에서,
*는 결합이 이루어지는 부분이고,
Ar1은 청구항 1에서 정의된 바와 같다.
3. The method of claim 2,
Formula 6 is a compound characterized in that the following formula 16:
[Formula 16]
Figure pat00085

In the formula (16),
* is the part where the bond is made,
Ar1 is as defined in claim 1.
제4항에 있어서,
상기 화학식 12는 하기 화학식 17인 것을 특징으로 하는 화합물:
[화학식 17]
Figure pat00086

상기 화학식 17에서,
*는 결합이 이루어지는 부분이다.
5. The method of claim 4,
Formula 12 is a compound characterized in that the following formula 17:
[Formula 17]
Figure pat00086

In Formula 17,
* is the part where the connection is made.
제1항에 있어서,
L은 단일결합이거나, 하기 L-1 내지 L-3 중에서 선택되는 링커인 것을 특징으로 하는 화합물:
Figure pat00087
Figure pat00088
Figure pat00089

L-1 내지 L-3에서,
*는 결합이 이루어지는 부분이다.
According to claim 1,
L is a single bond or a compound characterized in that it is a linker selected from the following L-1 to L-3:
Figure pat00087
Figure pat00088
Figure pat00089

In L-1 to L-3,
* is the part where the connection is made.
제1항에 있어서,
상기 화합물은 아래의 화합물로 이루어진 군에서 선택되는 것을 특징으로 하는 화합물:
Figure pat00090

Figure pat00091

Figure pat00092

Figure pat00093

Figure pat00094

Figure pat00095

Figure pat00096

Figure pat00097

Figure pat00098

Figure pat00099

Figure pat00100

Figure pat00101

Figure pat00102

Figure pat00103

Figure pat00104

Figure pat00105

Figure pat00106

Figure pat00107
According to claim 1,
The compound is a compound characterized in that it is selected from the group consisting of:
Figure pat00090

Figure pat00091

Figure pat00092

Figure pat00093

Figure pat00094

Figure pat00095

Figure pat00096

Figure pat00097

Figure pat00098

Figure pat00099

Figure pat00100

Figure pat00101

Figure pat00102

Figure pat00103

Figure pat00104

Figure pat00105

Figure pat00106

Figure pat00107
(i) 양극, (ii) 음극, 및 (iii) 상기 양극과 음극 사이에 개재된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서,
상기 1층 이상의 유기물층 중에서 적어도 하나는 제1항의 화학식 1로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자.
An organic electroluminescent device comprising (i) an anode, (ii) a cathode, and (iii) one or more organic material layers interposed between the anode and the cathode,
At least one of the one or more organic material layers is an organic electroluminescent device comprising a compound represented by the formula (1) of claim 1.
제10항에 있어서,
상기 유기물층은 정공 주입층, 정공 수송층, 정공 수송 보조층, 전자 수송층, 전자 수송 보조층 및 발광층으로 이루어진 군에서 선택되는 하나 이상의 층을 포함하는, 유기 전계 발광 소자.
11. The method of claim 10,
The organic material layer is an organic electroluminescent device comprising one or more layers selected from the group consisting of a hole injection layer, a hole transport layer, a hole transport auxiliary layer, an electron transport layer, an electron transport auxiliary layer, and a light emitting layer.
KR1020200074331A 2020-06-18 2020-06-18 Organic light-emitting compound and organic electroluminescent device using the same KR20210156913A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020200074331A KR20210156913A (en) 2020-06-18 2020-06-18 Organic light-emitting compound and organic electroluminescent device using the same
PCT/KR2021/007608 WO2021256871A1 (en) 2020-06-18 2021-06-17 Organic light-emitting compound and organic electroluminescent device using same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200074331A KR20210156913A (en) 2020-06-18 2020-06-18 Organic light-emitting compound and organic electroluminescent device using the same

Publications (1)

Publication Number Publication Date
KR20210156913A true KR20210156913A (en) 2021-12-28

Family

ID=79178104

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200074331A KR20210156913A (en) 2020-06-18 2020-06-18 Organic light-emitting compound and organic electroluminescent device using the same

Country Status (2)

Country Link
KR (1) KR20210156913A (en)
WO (1) WO2021256871A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114560844A (en) * 2022-04-28 2022-05-31 浙江华显光电科技有限公司 N-heteroaromatic derivative, organic light-emitting device, display panel and display device
KR102478386B1 (en) * 2022-03-16 2022-12-16 덕산네오룩스 주식회사 An organic electronic element comprising compound for organic electronic element and an electronic device thereof
WO2023234749A1 (en) * 2022-06-03 2023-12-07 주식회사 엘지화학 Compound and organic light-emitting device comprising same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150033082A (en) 2013-09-23 2015-04-01 에스케이케미칼주식회사 Compound for organic electroluminescent device and organic electroluminescent device comprising the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100987822B1 (en) * 2007-12-17 2010-10-13 (주)씨에스엘쏠라 Organic light emitting compound and organic light emitting device comprising the same
JP2010138121A (en) * 2008-12-12 2010-06-24 Canon Inc Triazine compound, and organic light emitting element employing the same
KR101694487B1 (en) * 2014-10-24 2017-01-11 (주)위델소재 Quinoxaline derivative compound, pyridopyrazine derivative compound and organic electroluminescent devices using the sames
KR102500272B1 (en) * 2015-09-16 2023-02-16 삼성디스플레이 주식회사 Compound and Organic light emitting device comprising same
CN106554323B (en) * 2015-09-30 2020-07-03 北京鼎材科技有限公司 Phenazine group-substituted polycyclic aromatic hydrocarbon derivative and application thereof
CN106554319B (en) * 2015-09-30 2020-07-21 北京鼎材科技有限公司 Quinazoline group-containing derivative and application thereof
CN106554352B (en) * 2015-09-30 2020-12-08 北京鼎材科技有限公司 Polycyclic aromatic hydrocarbon derivative containing naphthyridine group and application thereof
CN110878088A (en) * 2018-09-06 2020-03-13 北京鼎材科技有限公司 Compound and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150033082A (en) 2013-09-23 2015-04-01 에스케이케미칼주식회사 Compound for organic electroluminescent device and organic electroluminescent device comprising the same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102478386B1 (en) * 2022-03-16 2022-12-16 덕산네오룩스 주식회사 An organic electronic element comprising compound for organic electronic element and an electronic device thereof
WO2023177216A1 (en) * 2022-03-16 2023-09-21 덕산네오룩스 주식회사 Organic electric element including compound for organic electric element, and electronic device thereof
CN117337634A (en) * 2022-03-16 2024-01-02 德山新勒克斯有限公司 Organic electronic element comprising a compound for an organic electronic element and electronic device thereof
US11980045B1 (en) 2022-03-16 2024-05-07 Duk San Neolux Co., Ltd. Organic electric element including compound for organic electric element, and electronic device thereof
CN114560844A (en) * 2022-04-28 2022-05-31 浙江华显光电科技有限公司 N-heteroaromatic derivative, organic light-emitting device, display panel and display device
CN114560844B (en) * 2022-04-28 2022-08-16 浙江华显光电科技有限公司 N-heteroaromatic derivative, organic light-emitting device, display panel and display device
WO2023234749A1 (en) * 2022-06-03 2023-12-07 주식회사 엘지화학 Compound and organic light-emitting device comprising same

Also Published As

Publication number Publication date
WO2021256871A1 (en) 2021-12-23

Similar Documents

Publication Publication Date Title
KR20180022574A (en) Organic compounds and organic electro luminescence device comprising the same
CN115536633A (en) Compound and organic electroluminescent element comprising same
KR20170065317A (en) Organic compounds and organic electro luminescence device comprising the same
KR20180046150A (en) Organic compounds and organic electro luminescence device comprising the same
KR102160326B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102248650B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR20210156913A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR102199112B1 (en) Organic compound and organic electroluminescent device using the same
KR20190058748A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR102617611B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20220008636A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR20200067058A (en) Organic compound and organic electroluminescent device comprising the same
KR102692902B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101762482B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR102577794B1 (en) Organic electroluminescent device
KR20220003857A (en) Organic compound and organic electroluminescent device using the same
KR20210081637A (en) Organic compound and organic electroluminescent device using the same
KR20200142220A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR20230044757A (en) Organic compound and organic electroluminescent device using the same
KR20180128181A (en) Organic compounds and organic electro luminescence device comprising the same
KR102307342B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR102703928B1 (en) Organic compound and organic electroluminescent device comprising the same
KR20210043993A (en) Organic light-emitting compound and organic electroluminescent device comprising the same
KR20200119648A (en) Organic compound and organic electroluminescent device using the same
KR20200119647A (en) Organic compound and organic electroluminescent device comprising the same